PMID
Article Title
Citation
Organization
Download
View Data
Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections.
J Med Chem 59: 3215-30 (2016)
East China University of Science and Technology
Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
Eur J Med Chem 115: 121-31 (2016)
King Saud University
Discovery of a series of 8-(2,3-dihydro-1,4-benzoxazin-4-ylmethyl)-2-morpholino-4-oxo-chromene-6-carboxamides as PI3K?/? inhibitors for the treatment of PTEN-deficient tumours.
Bioorg Med Chem Lett 26: 2318-23 (2016)
AstraZeneca
Synthesis of azepino[4,5-b]indol-4-ones via MCR/free radical cyclization and in vitro-in silico studies as 5-Ht?R ligands.
Bioorg Med Chem Lett 26: 2333-8 (2016)
Universidad de Guanajuato
Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay.
Bioorg Med Chem Lett 26: 2365-9 (2016)
Sungkyunkwan University
Piperidine derivatives as nonprostanoid IP receptor agonists.
Bioorg Med Chem Lett 26: 2360-4 (2016)
Toray Industries Inc
Development of a potent and selective FLT3 kinase inhibitor by systematic expansion of a non-selective fragment-screening hit.
Bioorg Med Chem Lett 26: 2370-4 (2016)
The University of Tokyo
2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling.
Bioorg Med Chem Lett 26: 2308-13 (2016)
University of Cagliari
Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold.
Bioorg Med Chem Lett 26: 2328-32 (2016)
Novartis Institutes for BioMedical Research
Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
Eur J Med Chem 115: 94-108 (2016)
Peking University
Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Eur J Med Chem 115: 63-74 (2016)
National University of Singapore
Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
Eur J Med Chem 115: 53-62 (2016)
Shandong University
Thiadiazole derivatives as New Class ofß-glucuronidase inhibitors.
Bioorg Med Chem 24: 1909-18 (2016)
University of Karachi
Discovery of novel N,N-3-phenyl-3-benzylaminopropionanilides as potent inhibitors of cholesteryl ester transfer protein in vivo.
Bioorg Med Chem 24: 1811-8 (2016)
Shenyang Pharmaceutical University
2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis.
Eur J Med Chem 115: 14-25 (2016)
GlaxoSmithKline Medicines Research Centre
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR)ß Agonist.
J Med Chem 59: 3264-71 (2016)
Vitae Pharmaceuticals Inc
Design and evaluation of novel glutaminase inhibitors.
Bioorg Med Chem 24: 1819-39 (2016)
University of Pittsburgh
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Bioorg Med Chem 24: 1793-810 (2016)
Jagiellonian University Medical College
N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.
Bioorg Med Chem Lett 26: 1894-900 (2016)
Vanderbilt University Medical Center
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.
Bioorg Med Chem Lett 26: 2105-14 (2016)
AstraZeneca
Pharmacophore elucidation of phosphoiodyn A - Potent and selective peroxisome proliferator-activated receptorß/d agonists with neuroprotective activity.
Bioorg Med Chem Lett 26: 1889-93 (2016)
Texas Tech University Health Sciences Center
Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs.
Bioorg Med Chem Lett 26: 1869-72 (2016)
Vanderbilt University Medical Center
Identification of nonabsorbable inhibitors of the scavenger receptor-BI (SR-BI) for tissue-specific administration.
Bioorg Med Chem Lett 26: 1901-4 (2016)
GlaxoSmithKline
A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease.
J Med Chem 59: 3098-111 (2016)
Norgine Ltd
Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance.
J Med Chem 59: 3129-39 (2016)
Ferring Research Institute Inc.
Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions.
J Med Chem 59: 2962-72 (2016)
Universit£ de Sherbrooke
Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein.
Eur J Med Chem 113: 273-92 (2016)
University of Maryland
Discovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.
ACS Med Chem Lett 7: 335-9 (2016)
Shanghai Institute of Materia Medica
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors.
ACS Med Chem Lett 7: 324-9 (2016)
Merck Research Laboratories
Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI.
ACS Med Chem Lett 7: 312-7 (2016)
Merck Research Laboratories
Discovery of G Protein-Biased EP2 Receptor Agonists.
ACS Med Chem Lett 7: 306-11 (2016)
Ono Pharmaceutical Co., Ltd
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo.
ACS Med Chem Lett 7: 300-5 (2016)
AstraZeneca
Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aß-Mediated Mitochondrial Dysfunction.
ACS Med Chem Lett 7: 294-9 (2016)
University of Kansas
Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5.
ACS Med Chem Lett 7: 289-93 (2016)
Bristol-Myers Squibb Research & Development
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
ACS Med Chem Lett 7: 283-8 (2016)
Bristol-Myers Squibb Co.
Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models.
ACS Med Chem Lett 7: 277-82 (2016)
Xenon Pharmaceuticals Inc
Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aß Reduction in Rodents.
ACS Med Chem Lett 7: 271-6 (2016)
Bristol-Myers Squibb Co.
Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043.
ACS Med Chem Lett 7: 266-70 (2016)
University of Notre Dame
Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach.
ACS Med Chem Lett 7: 261-5 (2016)
Merck Research Laboratories
Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.
ACS Med Chem Lett 7: 250-5 (2016)
Whitman College
Astemizole Derivatives as Fluorescent Probes for hERG Potassium Channel Imaging.
ACS Med Chem Lett 7: 245-9 (2016)
Shandong University
Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors.
ACS Med Chem Lett 7: 229-34 (2016)
Virginia Tech
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells.
ACS Med Chem Lett 7: 223-8 (2016)
Genentech Inc
Potential Use of Inhibitors of Tankyrases and PARP-1 as Treatment for Cancer and Other Diseases.
ACS Med Chem Lett 7: 209-10 (2016)
Therachem Research Medilab (India) Pvt. Ltd.
Glutaminase GLS1 Inhibitors as Potential Cancer Treatment.
ACS Med Chem Lett 7: 207-8 (2016)
Therachem Research Medilab (India) Pvt. Ltd.
MALT1 Inhibitors May Potentially Treat Lymphomas and Autoimmune Disorders.
ACS Med Chem Lett 7: 205-6 (2016)
Therachem Research Medilab (India) Pvt. Ltd.
Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors.
ACS Med Chem Lett 7: 217-22 (2016)
GlaxoSmithKline
Cathepsin B Inhibitors: Combining Dipeptide Nitriles with an Occluding Loop Recognition Element by Click Chemistry.
ACS Med Chem Lett 7: 211-6 (2016)
University of Bonn
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis.
ACS Med Chem Lett 7: 198-203 (2016)
Merck Research Laboratories
Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists.
ACS Med Chem Lett 7: 192-7 (2016)
Roche Innovation Center Basel
New Colchicine-Derived Triazoles and Their Influence on Cytotoxicity and Microtubule Morphology.
ACS Med Chem Lett 7: 188-91 (2016)
University of Cologne
Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin Pathway.
ACS Med Chem Lett 7: 182-7 (2016)
University of Pittsburgh
Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation.
ACS Med Chem Lett 7: 177-81 (2016)
Southern Research
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666.
ACS Med Chem Lett 7: 162-6 (2016)
Epizyme, Inc.
Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300.
ACS Med Chem Lett 7: 151-5 (2016)
National Cancer Institute
Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains.
ACS Med Chem Lett 7: 145-50 (2016)
Constellation Pharmaceuticals
Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family.
ACS Med Chem Lett 7: 139-44 (2016)
University of Victoria
Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor.
ACS Med Chem Lett 7: 134-8 (2016)
Epizyme Inc.
Aminotriazole and Aminotetrazole Inhibitors of LSD1 as Epigenetic Modulators.
ACS Med Chem Lett 7: 132-3 (2016)
Dart Neuroscience LLC
Dihydropteridinone Inhibitors of BRD4.
ACS Med Chem Lett 7: 131-131 (2016)
Dart Neuroscience LLC
Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.
ACS Med Chem Lett 7: 128-30 (2016)
Therachem Research Medilab (India) Pvt. Ltd.
The"Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains.
J Med Chem 59: 3087-97 (2016)
University of Z£rich
Bcl-2/MDM2 Dual Inhibitors Based on Universal Pyramid-Like ?-Helical Mimetics.
J Med Chem 59: 3152-62 (2016)
Dalian University of Technology
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.
J Med Chem 59: 2928-41 (2016)
University of Minnesota
Synthesis and Structure-Activity Relationships of N-Dihydrocoptisine-8-ylidene Aromatic Amines and N-Dihydrocoptisine-8-ylidene Aliphatic Amides as Antiulcerative Colitis Agents Targeting XBP1.
J Nat Prod 79: 775-83 (2016)
Chinese Academy of Medical Sciences and Peking Union Medical College
2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kd Selective Inhibitors.
J Med Chem 59: 3532-48 (2016)
Gilead Sciences Inc
Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors.
Bioorg Med Chem 24: 1889-97 (2016)
Shenyang Pharmaceutical University
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
Bioorg Med Chem Lett 26: 1910-8 (2016)
Beijing Pearl Biotech Ltd
Rational modification of the lead molecule: Enhancement in the anticancer and dihydrofolate reductase inhibitory activity.
Bioorg Med Chem Lett 26: 1936-40 (2016)
Guru Nanak Dev University
Fragment-Linking Approach Using (19)F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors ofß-Secretase.
J Med Chem 59: 3732-49 (2016)
Amgen Inc
Discovery and modelling studies of natural ingredients from Gaultheria yunnanensis (FRANCH.) against phosphodiesterase-4.
Eur J Med Chem 114: 134-40 (2016)
Sun Yat-sen University
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.
Bioorg Med Chem Lett 26: 1947-53 (2016)
Vanderbilt University School of Medicine
Approaching the active conformation of 1,3-diaminopyrimidine based covalent inhibitors of Bruton's tyrosine kinase for treatment of Rheumatoid arthritis.
Bioorg Med Chem Lett 26: 1954-7 (2016)
KBP Biosciences
Fragment-based discovery of inhibitor scaffolds targeting the metallo-ß-lactamases NDM-1 and VIM-2.
Bioorg Med Chem Lett 26: 1973-7 (2016)
UiT The Arctic University of Norway
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptorsa antagonists.
Eur J Med Chem 114: 191-200 (2016)
Universit£"G. d'Annunzio"
Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
Eur J Med Chem 114: 170-90 (2016)
Punjabi University
Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
Eur J Med Chem 114: 162-9 (2016)
Qatar University
Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities.
Eur J Med Chem 114: 65-78 (2016)
Shandong University
Chroman-4-one and chromone based somatostatinß-turn mimetics.
Eur J Med Chem 114: 59-64 (2016)
University of Gothenburg
Design and synthesis of thiourea derivatives with sulfur-containing heterocyclic scaffolds as potential tyrosinase inhibitors.
Bioorg Med Chem 24: 1866-71 (2016)
East China University of Science and Technology
Comparison of the sulfonamide inhibition profiles of thea-,ß- and¿-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
Bioorg Med Chem Lett 26: 1941-6 (2016)
Universit£ degli Studi di Firenze
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
Bioorg Med Chem 24: 1683-95 (2016)
National and Kapodistrian University of Athens
Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
Bioorg Med Chem 24: 1729-40 (2016)
CSIR-Indian Institute of Chemical Technology
Recent progress on third generation covalent EGFR inhibitors.
Bioorg Med Chem Lett 26: 1861-8 (2016)
Pfizer Inc
Sclerotiamide: The First Non-Peptide-Based Natural Product Activator of Bacterial Caseinolytic Protease P.
J Nat Prod 79: 1193-7 (2016)
University of Oklahoma COBRE in Structural Biology
Identification of a Human Toll-Like Receptor (TLR) 8-Specific Agonist and a Functional Pan-TLR Inhibitor in 2-Aminoimidazoles.
J Med Chem 59: 3311-30 (2016)
University of Kansas
Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed fromaa- andaß-amino acids.
Bioorg Med Chem Lett 26: 1958-62 (2016)
China Pharmaceutical University
Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
Bioorg Med Chem Lett 26: 1988-92 (2016)
University of Lucknow
7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer.
Bioorg Med Chem Lett 26: 2000-4 (2016)
Cardiff University
D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.
Bioorg Med Chem Lett 26: 2088-91 (2016)
Johns Hopkins University
Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approach.
Bioorg Med Chem Lett 26: 2023-9 (2016)
AstraZeneca
Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Bioorg Med Chem 24: 1749-56 (2016)
Jiangxi Science & Technology Normal University
Antiretroviral (HIV-1) activity of azulene derivatives.
Bioorg Med Chem 24: 1653-7 (2016)
University of Tartu
Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.
Bioorg Med Chem 24: 1741-8 (2016)
Anhui Medical University
Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as a-glucosidase inhibitors.
Bioorg Chem 65: 167-74 (2016)
Jishou University
Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism.
J Med Chem 59: 3340-52 (2016)
Universit£ di Perugia
Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase.
Medchemcomm 6: 1767-1772 (2016)
Imperial College
Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase.
Medchemcomm 6: 1761-1766 (2016)
Imperial College
In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.
Bioorg Med Chem Lett 26: 2018-22 (2016)
Universidad Aut£noma del Estado de Morelos
Identification of PTP1B and ?-Glucosidase Inhibitory Serrulatanes from Eremophila spp. by Combined use of Dual High-Resolution PTP1B and ?-Glucosidase Inhibition Profiling and HPLC-HRMS-SPE-NMR.
J Nat Prod 79: 1063-72 (2016)
University of Copenhagen
An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.
J Med Chem 59: 3112-28 (2016)
University of Minnesota
Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1).
J Med Chem 59: 2478-96 (2016)
Ontario Institute for Cancer Research
Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Activea1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities.
J Med Chem 59: 2989-3002 (2016)
Takeda Pharmaceutical Co., Ltd
Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51.
J Med Chem 59: 2410-22 (2016)
Max Planck Institute of Psychiatry
1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.
Bioorg Med Chem 24: 1619-36 (2016)
Aptuit s.r.l
Isatin analogs as novel inhibitors of Candida spp.ß-carbonic anhydrase enzymes.
Bioorg Med Chem 24: 1648-52 (2016)
Bezmialem Vakif University
Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors.
Bioorg Med Chem Lett 26: 2057-64 (2016)
Novartis Institutes for BioMedical Research
Identification of a 5-[3-phenyl-(2-cyclic-ether)-methylether]-4-aminopyrrolo[2,3-d]pyrimidine series of IGF-1R inhibitors.
Bioorg Med Chem Lett 26: 2065-7 (2016)
Novartis Institutes for BioMedical Research
Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors.
Bioorg Chem 65: 146-58 (2016)
Tianjin University of Science and Technology
Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis.
J Med Chem 59: 2596-611 (2016)
University of Liverpool
The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic-industrial partnership.
Medchemcomm 6: 1420-1426 (2016)
University College London
Identification of novel GLUT inhibitors.
Bioorg Med Chem Lett 26: 1732-7 (2016)
Bayer Pharma AG
Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
Bioorg Med Chem 24: 1560-72 (2016)
University of Pardubice
Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (s1) receptor antagonists for the treatment of pain.
Bioorg Med Chem Lett 26: 2051-6 (2016)
Renmin Hospital of Wuhan University
Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-ß-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Bioorg Med Chem Lett 26: 2035-9 (2016)
Sichuan University
Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.
Chembiochem 17: 683-8 (2016)
University of Siena
Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry.
Eur J Med Chem 113: 258-72 (2016)
University of Waterloo
Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
Eur J Med Chem 113: 246-57 (2016)
China Pharmaceutical University
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.
Eur J Med Chem 113: 214-27 (2016)
University of Bordeaux
Synthesis, biological evaluation and structural analysis of novel peripherally active morphiceptin analogs.
Bioorg Med Chem 24: 1582-8 (2016)
Medical University of Lodz
Synthesis of tetracyclic iminosugars fused benzo[e][1,3]thiazin-4-one and their HIV-RT inhibitory activity.
Bioorg Med Chem Lett 26: 1738-41 (2016)
Hebei University
Target ?-catenin/CD44/Nanog axis in colon cancer cells by certain N'-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides.
Bioorg Med Chem Lett 26: 1664-70 (2016)
King Saud University
Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety.
Bioorg Med Chem Lett 26: 1794-8 (2016)
Jiangxi Science and Technology Normal University
Discovery of Bifunctional Oncogenic Target Inhibitors against Allosteric Mitogen-Activated Protein Kinase (MEK1) and Phosphatidylinositol 3-Kinase (PI3K).
J Med Chem 59: 2512-22 (2016)
The University of Michigan Medical School
Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives.
Bioorg Chem 65: 137-45 (2016)
Chulabhorn Research Institute
Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1).
J Med Chem 59: 3018-33 (2016)
University of Bonn
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
J Med Chem 59: 2794-809 (2016)
Amgen Inc
Structurally Diverse Mitochondrial Branched Chain Aminotransferase (BCATm) Leads with Varying Binding Modes Identified by Fragment Screening.
J Med Chem 59: 2452-67 (2016)
GlaxoSmithKline
Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis.
J Med Chem 59: 2468-77 (2016)
University of Bologna
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.
J Med Chem 59: 2423-35 (2016)
Martin-Luther University of Halle-Wittenberg
Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury.
J Med Chem 59: 2436-51 (2016)
Wenzhou Medical University
Structure-Based Design of an Iminoheterocyclicß-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aß in Nonhuman Primates.
J Med Chem 59: 3231-48 (2016)
Merck Research Laboratories
Limonoids and Triterpenoids as 11?-HSD1 Inhibitors from Walsura robusta.
J Nat Prod 79: 899-906 (2016)
Chinese Academy of Sciences
Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.
Bioorg Med Chem 24: 1573-81 (2016)
Mercachem
Emerging targets and new small molecule therapies in Parkinson's disease treatment.
Bioorg Med Chem 24: 1419-30 (2016)
School of Medicine of University of Electronic Science and Technology of China
The Synthesis of 1,3,5-triazine Derivatives and JNJ7777120 Analogues with Histamine H4 Receptor Affinity and Their Interaction with PTEN Promoter.
Chem Biol Drug Des 88: 254-63 (2016)
Jagiellonian University Medical College
Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo Efficacy.
J Med Chem 59: 2841-6 (2016)
University of Southern Denmark
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.
J Med Chem 59: 2648-59 (2016)
University of Minnesota
Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema.
J Med Chem 59: 2674-87 (2016)
Chinese Academy of Sciences
Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents.
Eur J Med Chem 112: 367-72 (2016)
Shanghai Institute of Materia Medica
Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors.
Bioorg Med Chem Lett 26: 1803-8 (2016)
Merck & Co.
Isothiazolo[4,3-b]pyridines as inhibitors of cyclin G associated kinase : synthesis, structure-activity relationship studies and antiviral activity.
Medchemcomm 6: 1666-1672 (2016)
KU Leuven
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.
J Med Chem 59: 2820-40 (2016)
Bristol-Myers Squibb Research and Development
MutT Homolog 1 (MTH1): The Silencing of a Target.
J Med Chem 59: 2343-5 (2016)
Nerviano Medical Sciences srl
Novel 2,4-diaminopyrimidines bearing tetrahydronaphthalenyl moiety against anaplastic lymphoma kinase (ALK): Synthesis, in vitro, ex vivo, and in vivo efficacy studies.
Bioorg Med Chem Lett 26: 1720-5 (2016)
Chungbuk National University
Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
Bioorg Med Chem Lett 26: 1680-4 (2016)
Jiangxi Science and Technology Normal University
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists.
Eur J Med Chem 113: 102-33 (2016)
Rhône-Poulenc Rorer
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives.
Eur J Med Chem 113: 50-62 (2016)
Egyptian Russian University
Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists.
Eur J Med Chem 113: 11-27 (2016)
Universit£ di Ferrara
4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP).
Eur J Med Chem 113: 1-10 (2016)
Gazi University
Sulfonamide inhibition studies of theß-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13.
Bioorg Med Chem Lett 26: 1821-6 (2016)
Recep Tayyip Erdogan University
Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.
J Med Chem 59: 2760-79 (2016)
Pharmaron-Beijing Co., Ltd
Humudifucol and Bioactive Prenylated Polyphenols from Hops (Humulus lupulus cv."Cascade").
J Nat Prod 79: 590-7 (2016)
University of Naples Federico II
Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.
J Med Chem 59: 2579-95 (2016)
The University of Montana
Structure activity relationship studies on chemically non-reactive glycine sulfonamide inhibitors of diacylglycerol lipase.
Bioorg Med Chem 24: 1455-68 (2016)
Bristol-Myers Squibb Co.
Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.
Bioorg Med Chem 24: 1528-39 (2016)
China Pharmaceutical University
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.
Bioorg Med Chem Lett 26: 1827-30 (2016)
University of North Carolina at Greensboro
A Novel Inhibitor of the Obesity-Related Protein FTO.
Biochemistry 55: 1516-22 (2016)
Basic Medical College of Zhengzhou University
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor.
J Med Chem 59: 4462-75 (2016)
Boehringer Ingelheim RCV GmbH & Co KG
Chemical Space of DNA-Encoded Libraries.
J Med Chem 59: 6629-44 (2016)
University of Utah
Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism Approach.
Chem Biol Drug Des 88: 241-53 (2016)
Shandong University
Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities.
J Nat Prod 79: 760-6 (2016)
Huazhong University of Science and Technology
Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
Bioorg Med Chem 24: 1513-9 (2016)
Farmaceutiche ed Ambientali (CHIBIOFARAM) Universit£ degli Studi di Messina
Synthesis, biological evaluation and molecular docking studies of 2-piperazin-1-yl-quinazolines as platelet aggregation inhibitors and ligands of integrinaIIbß3.
Bioorg Med Chem Lett 26: 1839-43 (2016)
A.V. Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine
Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2).
J Med Chem 59: 2734-46 (2016)
University of Minnesota
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.
J Med Chem 59: 7029-65 (2016)
Vrije Universiteit Amsterdam
Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors.
Bioorg Med Chem 24: 1446-54 (2016)
Shandong University
Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation.
Eur J Med Chem 112: 347-66 (2016)
University of Z£rich
Inhibition of human DNA topoisomerase IIa by two novel ellipticine derivatives.
Bioorg Med Chem Lett 26: 1809-12 (2016)
Vanderbilt University School of Medicine
Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.
Bioorg Med Chem 24: 1469-79 (2016)
Purdue University
Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors.
Bioorg Med Chem 24: 1495-503 (2016)
Jiangxi Science & Technology Normal University
Altered activity profile of a tertiary silanol analog of multi-targeting nuclear receptor modulator T0901317.
Bioorg Med Chem Lett 26: 1817-20 (2016)
The University of Tokyo
Identification of novel estrogen receptor (ER) agonists that have additional and complementary anti-cancer activities via ER-independent mechanism.
Bioorg Med Chem Lett 26: 1844-8 (2016)
Kyung Hee University
Plumbagin, Juglone, and Boropinal as Novel TRPA1 Agonists.
J Nat Prod 79: 697-703 (2016)
Universit£t Leipzig
Design and Synthesis of Benzimidazoles As Novel Corticotropin-Releasing Factor 1 Receptor Antagonists.
J Med Chem 59: 2551-66 (2016)
Takeda Pharmaceutical Co., Ltd
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).
J Nat Prod 79: 616-28 (2016)
Monash University (Parkville Campus)
Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.
J Nat Prod 79: 680-4 (2016)
Stanford University
Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
Eur J Med Chem 112: 280-8 (2016)
Dalian Institute of Chemical Physics
Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation.
Eur J Med Chem 112: 258-69 (2016)
Jagiellonian University Medical College
New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold.
Eur J Med Chem 112: 252-7 (2016)
University of Ljubljana
Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.
Eur J Med Chem 112: 231-51 (2016)
Anhui Medical University
A potent and selective inhibitor targeting human and murine 12/15-LOX.
Bioorg Med Chem 24: 1183-90 (2016)
University of California
SAR exploration at the C-3 position of tetrahydro-ß-carboline sstr3 antagonists.
Bioorg Med Chem Lett 26: 1529-35 (2016)
Merck Research Laboratories
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family.
J Med Chem 59: 2747-59 (2016)
Universit£ degli Studi di Siena
Synthesis of pyrimido[4,5-c]azepine- and pyrimido[4,5-c]oxepine-based¿-secretase modulators.
Bioorg Med Chem Lett 26: 1554-7 (2016)
Bristol-Myers Squibb Co.
Identification of potent and selective MTH1 inhibitors.
Bioorg Med Chem Lett 26: 1503-7 (2016)
MD Anderson Cancer Center
Design and synthesis of [(125)I]Pyricoxib: A novel (125)I-labeled cyclooxygenase-2 (COX-2) inhibitors.
Bioorg Med Chem Lett 26: 1516-20 (2016)
University of Alberta
Stimulation of cortical bone formation with thienopyrimidine based inhibitors of Notum Pectinacetylesterase.
Bioorg Med Chem Lett 26: 1525-8 (2016)
Lexicon Pharmaceuticals, Inc.
Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
Bioorg Med Chem 24: 1331-45 (2016)
Shenyang Pharmaceutical University
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists.
Bioorg Med Chem 24: 1384-91 (2016)
Vitae Pharmaceuticals
Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2.
Eur J Med Chem 112: 209-16 (2016)
Saarland University
Design and synthesis of novel tamoxifen analogues that avoid CYP2D6 metabolism.
Eur J Med Chem 112: 171-9 (2016)
German University in Cairo
The natural diterpene tonantzitlolone A and its synthetic enantiomer inhibit cell proliferation and kinesin-5 function.
Eur J Med Chem 112: 164-70 (2016)
Hannover Medical School (MHH)
A new GLP-1 analogue with prolonged glucose-lowering activity in vivo via backbone-based modification at the N-terminus.
Bioorg Med Chem 24: 1163-70 (2016)
Peking University
Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.
ACS Chem Biol 11: 1296-304 (2016)
Stony Brook University
Synthesis, a-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
Bioorg Chem 65: 100-9 (2016)
Universiti Teknologi MARA (UiTM), Puncak Alam Campus
Preparation and Evaluation of Radiolabeled Antibody Recruiting Small Molecules That Target Prostate-Specific Membrane Antigen for Combined Radiotherapy and Immunotherapy.
J Med Chem 59: 2660-73 (2016)
McMaster University
Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
J Med Chem 59: 1747-60 (2016)
China Pharmaceutical University
Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
J Med Chem 59: 2704-17 (2016)
Amgen Inc
Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists.
J Med Chem 59: 3249-63 (2016)
National Institute of Diabetes and Digestive and Kidney Diseases
Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.
Eur J Med Chem 112: 114-29 (2016)
Mendeleyev University of Chemical Technology
Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity.
Eur J Med Chem 112: 99-105 (2016)
University of Milan
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy.
Eur J Med Chem 112: 81-90 (2016)
Shanghai Institute of Materia Medica
Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties.
Eur J Med Chem 112: 66-80 (2016)
Universit£ degli Studi di Sassari
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
J Med Chem 59: 2612-32 (2016)
University of Siena
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.
J Med Chem 59: 2067-82 (2016)
Universit£t W£rzburg
Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIß.
J Med Chem 59: 1830-9 (2016)
University of California
Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
Bioorg Med Chem Lett 26: 1508-11 (2016)
Hefei University of Technology
Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer.
J Med Chem 59: 6580-94 (2016)
Dalian Medical University
De Novo Design at the Edge of Chaos.
J Med Chem 59: 4077-86 (2016)
Swiss Federal Institute of Technology (ETH)
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi.
J Med Chem 59: 2261-6 (2016)
National Institute of Advanced Industrial Science and Technology (AIST)
Application of PEG-400 as a green biodegradable polymeric medium for the catalyst-free synthesis of spiro-dihydropyridines and their use as acetyl and butyrylcholinesterase inhibitors.
Bioorg Med Chem 24: 1408-17 (2016)
Persian Gulf University
Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies.
Bioorg Med Chem 24: 1392-401 (2016)
In£n£ University
Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease.
Bioorg Med Chem 24: 1241-54 (2016)
Yamagata University
Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors.
Bioorg Med Chem Lett 26: 1571-5 (2016)
Beijing University of Technology
Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.
J Med Chem 59: 2346-61 (2016)
AstraZeneca
Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.
J Med Chem 59: 7011-28 (2016)
Astraea Therapeutics
Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods.
J Med Chem 59: 2054-66 (2016)
Vanderbilt University School of Medicine
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
J Med Chem 59: 6595-628 (2016)
University of Bonn
Optimization of N'-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocket.
Bioorg Med Chem Lett 26: 1605-11 (2016)
Abbott Healthcare Products BV
Development of 3-(4-aminosulphonyl)-phenyl-2-mercapto-3H-quinazolin-4-ones as inhibitors of carbonic anhydrase isoforms involved in tumorigenesis and glaucoma.
Bioorg Med Chem 24: 1402-7 (2016)
DAIS
Synthesis, biological evaluation and molecular modeling of pseudo-peptides based statine as inhibitors for human tissue kallikrein 5.
Eur J Med Chem 112: 39-47 (2016)
Universidade Federal Fluminense
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity.
Eur J Med Chem 112: 20-32 (2016)
University of Manchester
Simple N(e)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
Bioorg Med Chem Lett 26: 1612-7 (2016)
Jiangsu University
Dihydropyrano [2,3-c] pyrazole: Novel in vitro inhibitors of yeast a-glucosidase.
Bioorg Chem 65: 61-72 (2016)
King Abdulaziz University
Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
Eur J Med Chem 112: 1-19 (2016)
Universit£ di Modena e Reggio Emilia
Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity.
Chem Biol Drug Des 88: 188-96 (2016)
Ahi Evran University
Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure-Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program.
J Med Chem 59: 1818-29 (2016)
Merck Research Laboratories
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.
Eur J Med Chem 111: 193-201 (2016)
San Raffaele Scientific Institute
A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor.
Bioorg Med Chem Lett 26: 1365-70 (2016)
Mitsubishi Tanabe Pharma Corporation
In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors.
Bioorg Med Chem Lett 26: 1624-8 (2016)
University of British Columbia
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Bioorg Med Chem 24: 1298-307 (2016)
Birla Institute of Technology
Potenta-amino-ß-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies.
Eur J Med Chem 111: 138-59 (2016)
Italian Institute of Technology
Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening.
Chem Biol Drug Des 88: 178-87 (2016)
Southern Research Institute
Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors.
ACS Chem Biol 11: 1245-54 (2016)
Technical University of Munich
Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues.
J Med Chem 59: 2244-54 (2016)
University of Copenhagen
Discovery and Characterization of Biased Allosteric Agonists of the Chemokine Receptor CXCR3.
J Med Chem 59: 2222-43 (2016)
Friedrich-Alexander University
2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
Bioorg Med Chem 24: 1231-40 (2016)
Seoul National University
Synthesis of benzofuran derivatives as selective inhibitors of tissue-nonspecific alkaline phosphatase: effects on cell toxicity and osteoblast-induced mineralization.
Bioorg Med Chem Lett 26: 1457-9 (2016)
Universit£ de Lyon
Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, ß-glucuronidase inhibiton and their molecular docking studies.
Bioorg Chem 65: 48-56 (2016)
Universiti Teknologi MARA (UiTM), Puncak Alam Campus
DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors.
J Med Chem 59: 2163-78 (2016)
GlaxoSmithKline
Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines.
Eur J Med Chem 110: 326-39 (2016)
La Trobe University
Synthesis and biology of ring-modified l-Histidine containing thyrotropin-releasing hormone (TRH) analogues.
Eur J Med Chem 111: 72-83 (2016)
National Institute of Pharmaceutical Education and Research
Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria.
Eur J Med Chem 111: 33-45 (2016)
University of Manchester
Anion inhibition studies of theß-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
Bioorg Med Chem Lett 26: 1406-10 (2016)
Universit£ degli Studi di Firenze
Natural Products as Sources of New Drugs from 1981 to 2014.
J Nat Prod 79: 629-61 (2016)
NIH Special Volunteer
Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore.
Bioorg Med Chem Lett 26: 1443-51 (2016)
Merck KGaA
Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
Bioorg Med Chem 24: 938-56 (2016)
Baylor University
Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.
Eur J Med Chem 110: 302-10 (2016)
Yonsei University
2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship study.
Eur J Med Chem 111: 1-14 (2016)
Griffith University
One-pot synthesis of tetrazole-1,2,5,6-tetrahydronicotinonitriles and cholinesterase inhibition: Probing the plausible reaction mechanism via computational studies.
Bioorg Chem 65: 38-47 (2016)
University of Karachi
Synthesis and pharmacological characterization of novel xanthine carboxylate amides as A2A adenosine receptor ligands exhibiting bronchospasmolytic activity.
Bioorg Chem 65: 26-37 (2016)
Panjab University
5-Substituted 3-isopropyl-7-[4-(2-pyridyl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidines with anti-proliferative activity as potent and selective inhibitors of cyclin-dependent kinases.
Eur J Med Chem 110: 291-301 (2016)
Palack£ University and Institute of Experimental Botany AS CR
Sulfonamide inhibition studies of theß-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
Bioorg Med Chem 24: 1115-20 (2016)
Universit£ degli Studi di Firenze
Structure-activity relationship study of 4-(thiazol-5-yl)benzoic acid derivatives as potent protein kinase CK2 inhibitors.
Bioorg Med Chem 24: 1136-41 (2016)
Kyoto University
Anti-inflammatory and antioxidant properties of a novel resveratrol-salicylate hybrid analog.
Bioorg Med Chem Lett 26: 1411-5 (2016)
University of Alberta
Arylboronic acids as dual-action FAAH and TRPV1 ligands.
Bioorg Med Chem Lett 26: 1401-5 (2016)
Sapienza University of Rome
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development.
Bioorg Med Chem Lett 26: 1475-9 (2016)
Merck Research Laboratories
The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins.
Bioorg Med Chem Lett 26: 1485-9 (2016)
Campus Inc
Design and optimization of tricyclic gamma-secretase modulators.
Bioorg Med Chem Lett 26: 1498-502 (2016)
Bristol-Myers Squibb Research and Development
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators.
J Med Chem 59: 2179-91 (2016)
University of Salerno
Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions.
J Med Chem 59: 5563-86 (2016)
Chinese Academy of Sciences
Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studies.
Medchemcomm 5: 1507-1514 (2014)
The University of Arizona
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine.
J Nat Prod 79: 281-92 (2016)
Peking University
Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.
Eur J Med Chem 110: 259-66 (2016)
Egyptian Russian University
New quinoline derivatives as nicotinic receptor modulators.
Eur J Med Chem 110: 246-58 (2016)
University of Florence
Design, synthesis and biological evaluation of 3'-benzylated analogs of 3'-epi-neoponkoranol as potenta-glucosidase inhibitors.
Eur J Med Chem 110: 224-36 (2016)
China Pharmaceutical University
Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerfulß-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomalß-galactosidase.
Bioorg Med Chem Lett 26: 1438-42 (2016)
Graz University of Technology
Optimization by Molecular Fine Tuning of Dihydro-ß-agarofuran Sesquiterpenoids as Reversers of P-Glycoprotein-Mediated Multidrug Resistance.
J Med Chem 59: 1880-90 (2016)
Instituto Universitario de Bio-Org£nica"Antonio Gonz£lez"
Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
Chem Biol Drug Des 88: 43-53 (2016)
Yogi Vemana University
Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines.
Bioorg Med Chem Lett 26: 1229-32 (2016)
Bristol-Myers Squibb Discovery
Sulfonamide inhibition studies of the¿-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
Bioorg Med Chem Lett 26: 1253-9 (2016)
Universit£ degli Studi di Firenze
Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines.
Eur J Med Chem 110: 195-203 (2016)
Dalian Medical University
Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors.
Eur J Med Chem 110: 181-94 (2016)
University of Namur
Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Bioorg Med Chem 24: 1050-62 (2016)
Institute of Physiologically Active Compounds Russian Academy of Sciences
Pyrazole antagonists of the CB1 receptor with reduced brain penetration.
Bioorg Med Chem 24: 1063-70 (2016)
RTI International
Pyridoxine hydroxamic acids as novel HIV-integrase inhibitors.
Bioorg Med Chem Lett 26: 1233-6 (2016)
Ambrilia Biopharma Inc.
Identification and characterization of potent, selective and metabolically stable IKKß inhibitor.
Bioorg Med Chem Lett 26: 1120-3 (2016)
The Catholic University of Korea
Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors.
Eur J Med Chem 109: 371-9 (2016)
China Pharmaceutical University
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
J Med Chem 59: 1967-83 (2016)
Uppsala University
Mimicking of Arginine by Functionalized N(¿)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
J Med Chem 59: 1925-45 (2016)
University of Regensburg
Engineering of a Novel Simplified Human Insulin-Like Peptide 5 Agonist.
J Med Chem 59: 2118-25 (2016)
The University of Queensland
Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
J Med Chem 59: 1176-83 (2016)
University of Toronto
N-Acyl Dehydrotyrosines, Tyrosinase Inhibitors from the Marine Bacterium Thalassotalea sp. PP2-459.
J Nat Prod 79: 447-50 (2016)
University of Rhode Island
Discovery of potent anti-tuberculosis agents targeting leucyl-tRNA synthetase.
Bioorg Med Chem 24: 1023-31 (2016)
NAS of Ukraine
Symmetric 4,4'-(piperidin-4-ylidenemethylene)bisphenol derivatives as novel tunable estrogen receptor (ER) modulators.
Bioorg Med Chem 24: 1089-94 (2016)
Tohoku Pharmaceutical University
Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
Bioorg Med Chem Lett 26: 1124-9 (2016)
Karos Pharmaceuticals
4H-Thieno[3,2-c]chromene based inhibitors of Notum Pectinacetylesterase.
Bioorg Med Chem Lett 26: 1184-7 (2016)
Lexicon Pharmaceuticals, Inc.
Inhibition of monoamine oxidase by benzoxathiolone analogues.
Bioorg Med Chem Lett 26: 1200-4 (2016)
North-West University
The Halicylindramides, Farnesoid X Receptor Antagonizing Depsipeptides from a Petrosia sp. Marine Sponge Collected in Korea.
J Nat Prod 79: 499-506 (2016)
Daegu-Gyeongbuk Medical Innovation Foundation
Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.
J Med Chem 59: 1232-8 (2016)
University of Gothenburg
Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus.
Eur J Med Chem 110: 133-50 (2016)
Dipartimento di Farmacia Universit£ di Napoli"Federico II"
Synthesis and evaluation of colletoic acid core derivatives.
Eur J Med Chem 110: 126-32 (2016)
St. Jude Children's Research Hospital
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
Eur J Med Chem 109: 360-70 (2016)
Universit£ de Lille
Potent Small Agonists of Protease Activated Receptor 2.
ACS Med Chem Lett 7: 105-10 (2016)
The University of Queensland
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR.
ACS Med Chem Lett 7: 100-4 (2016)
Genentech
Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat.
ACS Med Chem Lett 7: 94-9 (2016)
AstraZeneca
Optimizing Ligand Efficiency of Selective Androgen Receptor Modulators (SARMs).
ACS Med Chem Lett 7: 83-8 (2016)
GlaxoSmithKline
Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo.
ACS Med Chem Lett 7: 72-6 (2016)
Novartis Institutes for BioMedical Research
Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis.
ACS Med Chem Lett 7: 56-61 (2016)
Birla Institute of Technology
Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist.
ACS Med Chem Lett 7: 51-5 (2016)
Zydus Research Centre
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer.
ACS Med Chem Lett 7: 40-5 (2016)
Bristol-Myers Squibb Research and Development
Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors.
ACS Med Chem Lett 7: 34-9 (2016)
BioFocus
SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious ROR¿ Inhibitor.
ACS Med Chem Lett 7: 23-7 (2016)
Central Pharmaceutical Research Institute
Sulfonamide Derivatives and Pharmaceutical Applications Thereof.
ACS Med Chem Lett 7: 12-4 (2016)
Temple University
Cyclopropanamine Compounds and Use Thereof.
ACS Med Chem Lett 7: 10-1 (2016)
Temple University
Discovery of benzenesulfonamide derivatives as potent PI3K/mTOR dual inhibitors with in vivo efficacies against hepatocellular carcinoma.
Bioorg Med Chem 24: 957-66 (2016)
Second Military Medical University
Discovery of novel phenoxazinone derivatives as DKK1/LRP6 interaction inhibitors: Synthesis, biological evaluation and structure-activity relationships.
Bioorg Med Chem 24: 1014-22 (2016)
Aristotle University of Thessaloniki
Insight to the binding mode of triazole RGD-peptidomimetics to integrin-rich cancer cells by NMR and molecular modeling.
Bioorg Med Chem 24: 989-94 (2016)
University of Milano
ß-Hydroxyacyl-acyl Carrier Protein Dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: Structure Determination, Enzymatic Characterization, and Cross-Inhibition Studies.
Biochemistry 55: 1091-9 (2016)
Brookhaven National Laboratory
Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.
Eur J Med Chem 109: 350-9 (2016)
Shenyang Pharmaceutical University
New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III.
J Med Chem 59: 914-24 (2016)
University of Copenhagen
Oxaspirol B with p97 Inhibitory Activity and Other Oxaspirols from Lecythophora sp. FL1375 and FL1031, Endolichenic Fungi Inhabiting Parmotrema tinctorum and Cladonia evansii.
J Nat Prod 79: 340-52 (2016)
University of Arizona
Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity.
J Med Chem 59: 2328-42 (2016)
Amgen Inc
Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
Bioorg Med Chem 24: 976-81 (2016)
University of Florida College of Medicine
Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Bioorg Med Chem 24: 812-9 (2016)
Jiangxi Science & Technology Normal University
Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.
Bioorg Med Chem 24: 902-9 (2016)
Westf£lische Wilhelms-Universit£t
A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms.
Bioorg Med Chem 24: 1095-105 (2016)
University of Chieti-Pescara
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Bioorg Med Chem Lett 26: 1260-4 (2016)
Merck Research Laboratories
Structural determinants of subtype selectivity and functional activity of angiotensin II receptors.
Bioorg Med Chem Lett 26: 1355-9 (2016)
Uppsala University
Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping.
Bioorg Med Chem Lett 26: 1218-23 (2016)
RIKEN
Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers.
Bioorg Med Chem Lett 26: 1282-6 (2016)
Dongguk University-Seoul
Discovery of highly selective CRAF inhibitors, 3-carboxamido-2H-indazole-6-arylamide: In silico FBLD design, synthesis and evaluation.
Bioorg Med Chem Lett 26: 1188-92 (2016)
Hanyang University
A Dual Non-ATP Analogue Inhibitor of Aurora Kinases A and B, Derived from Resorcinol with a Mixed Mode of Inhibition.
Chem Biol Drug Des 87: 958-67 (2016)
Jawaharlal Nehru Centre for Advanced Scientific Research
Discovery of Dual Inhibitors for Wild Type and D816V Mutant of c-KIT Kinase through Virtual and Biochemical Screening of Natural Products.
J Nat Prod 79: 293-9 (2016)
Sejong University
Pyrrole: An emerging scaffold for construction of valuable therapeutic agents.
Eur J Med Chem 110: 13-31 (2016)
Padmashri Vikhe Patil College
Kinetically Selective Inhibitors of Human Carbonic Anhydrase Isozymes I, II, VII, IX, XII, and XIII.
J Med Chem 59: 2083-93 (2016)
Uppsala University
Synthesis of Novel Oxazolo[4,5-b]pyridine-2-one based 1,2,3-triazoles as Glycogen Synthase Kinase-3ß Inhibitors with Anti-inflammatory Potential.
Chem Biol Drug Des 87: 918-26 (2016)
Hamdard University (Jamia Hamdard)
Dissecting structure-activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation.
Bioorg Med Chem Lett 26: 1265-71 (2016)
Massachusetts General Hospital
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Bioorg Med Chem Lett 26: 1245-8 (2016)
Novartis Institutes for BioMedical Research
Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors.
Bioorg Med Chem Lett 26: 1224-8 (2016)
Shenyang Pharmaceutical University
Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERG.
Bioorg Med Chem Lett 26: 1156-60 (2016)
Takeda Pharmaceutical Co., Ltd
Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
Bioorg Med Chem Lett 26: 1337-41 (2016)
Jamia Hamdard (Hamdard University)
Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.
Bioorg Med Chem 24: 982-8 (2016)
Harran University
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
Eur J Med Chem 109: 294-304 (2016)
Shandong University
Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma.
J Med Chem 59: 1727-46 (2016)
Sygnature Discovery Limited
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII.
Bioorg Med Chem 24: 921-7 (2016)
Universit£ di Pisa
Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19.
J Med Chem 59: 1078-101 (2016)
The Institute of Cancer Research
Investigation ofa-conotoxin unbinding using umbrella sampling.
Bioorg Med Chem Lett 26: 1296-300 (2016)
Ocean University of China
Ferulic acid-carbazole hybrid compounds: Combination of cholinesterase inhibition, antioxidant and neuroprotection as multifunctional anti-Alzheimer agents.
Bioorg Med Chem 24: 886-93 (2016)
Southeast University
Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action.
Bioorg Med Chem 24: 894-901 (2016)
National University of La Plata
Design, synthesis and biological evaluation of novel analgesic agents targeting both cyclooxygenase and TRPV1.
Bioorg Med Chem 24: 849-57 (2016)
Henan University
Structural features underlying raloxifene's biophysical interaction with bone matrix.
Bioorg Med Chem 24: 759-67 (2016)
Lilly Research Laboratories
Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives.
Bioorg Med Chem Lett 26: 1209-13 (2016)
Ono Pharmaceutical Co., Ltd
Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide.
Bioorg Med Chem Lett 26: 1193-5 (2016)
Waseda University
A new chromanone derivative isolated from Hypericum lissophloeus (Hypericaceae) potentiates GABAA receptor currents in a subunit specific fashion.
Bioorg Med Chem 24: 681-5 (2016)
University of Graz
Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions.
J Med Chem 59: 5970-86 (2016)
University Jena
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.
J Med Chem 59: 1149-64 (2016)
Intra-Cellular Therapies Inc
Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia.
J Med Chem 59: 1984-2004 (2016)
High Magnetic Field Laboratory
Potentµ-Opioid Receptor Agonists from Cyclic Peptides Tyr-c[D-Lys-Xxx-Tyr-Gly]: Synthesis, Biological, and Structural Evaluation.
J Med Chem 59: 1239-45 (2016)
Torrey Pines Institute for Molecular Studies
Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.
J Med Chem 59: 1840-53 (2016)
Instituto de Qu£mica M£dica
Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins).
J Med Chem 59: 854-66 (2016)
Salk Institute
Turmeric Sesquiterpenoids: Expeditious Resolution, Comparative Bioactivity, and a New Bicyclic Turmeronoid.
J Nat Prod 79: 267-73 (2016)
Universit£ del Piemonte Orientale
Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors.
Bioorg Med Chem 24: 877-85 (2016)
Institute of Technology & Science-Pilani
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.
Bioorg Med Chem Lett 26: 1314-8 (2016)
Cubist Pharmaceuticals
Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists.
Bioorg Med Chem Lett 26: 1329-32 (2016)
Aptuit s.r.l
Identification of six new lupane-type triterpenoids from Acanthopanax koreanum leaves and their tyrosinase inhibitory activities.
Bioorg Med Chem Lett 26: 1061-7 (2016)
Catholic University of Daegu
Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.
Eur J Med Chem 109: 268-75 (2016)
Universit£ d'Orl£ans
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
Eur J Med Chem 109: 276-86 (2016)
Medical University of Lodz
Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid.
J Med Chem 59: 1217-31 (2016)
Catabasis Pharmaceuticals
Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's.
Bioorg Med Chem Lett 26: 747-50 (2016)
Linyi People's Hospital
Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
Bioorg Med Chem Lett 26: 1348-54 (2016)
Merck Research Laboratories
Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5a-reductase inhibitors.
Bioorg Med Chem 24: 779-88 (2016)
University Institute of Pharmaceutical Sciences
From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II).
J Med Chem 59: 965-84 (2016)
Monash University (Parkville Campus)
Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
Bioorg Med Chem 24: 735-41 (2016)
Warsaw University of Technology
New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations.
Bioorg Med Chem 24: 721-34 (2016)
CNRS
Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo tool.
Bioorg Med Chem Lett 26: 751-6 (2016)
Vanderbilt University Medical Center
Carbazole-containing sulfonamides and sulfamides: Discovery of cryptochrome modulators as antidiabetic agents.
Bioorg Med Chem Lett 26: 757-60 (2016)
Reset Therapeutics, Inc.
2,3-Dihydrobenzofuran privileged structures as new bioinspired lead compounds for the design of mPGES-1 inhibitors.
Bioorg Med Chem 24: 820-6 (2016)
Universit£ di Salerno
Design and discovery of new pyrimidine coupled nitrogen aromatic rings as chelating groups of JMJD3 inhibitors.
Bioorg Med Chem Lett 26: 721-5 (2016)
Chinese Academy of Sciences
Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists.
Bioorg Med Chem Lett 26: 734-8 (2016)
North-West University
Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
Eur J Med Chem 109: 238-46 (2016)
University of Wisconsin
Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.
Eur J Med Chem 109: 199-205 (2016)
Central South University
Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
Eur J Med Chem 109: 216-37 (2016)
Fondazione Istituto Italiano di Tecnologia
Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.
Eur J Med Chem 109: 173-86 (2016)
CNRS UPR2301
Design, synthesis, and biological evaluation of novel thiazolidinediones as PPAR¿/FFAR1 dual agonists.
Eur J Med Chem 109: 157-72 (2016)
Suez Canal University
Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model.
Bioorg Med Chem Lett 26: 742-6 (2016)
Novartis Institutes for BioMedical Research
4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.
Bioorg Med Chem Lett 26: 1249-52 (2016)
Gedeon Richter Plc
Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.
Bioorg Med Chem Lett 26: 778-81 (2016)
Shanghai Institute of Materia Medica
Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.
Eur J Med Chem 109: 124-33 (2016)
University of Regensburg
Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na(+)/Ca(2+) exchanger.
Eur J Med Chem 109: 114-23 (2016)
Universidad Aut£noma de Madrid
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity.
Eur J Med Chem 109: 99-106 (2016)
University of Siena
Synthesis and tyrosinase inhibition activity of trans-stilbene derivatives.
Bioorg Chem 64: 97-102 (2016)
Indian Institute of Integrative Medicine
The Medicinal Chemistry of Dengue Virus.
J Med Chem 59: 5622-49 (2016)
Heidelberg University
Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.
J Med Chem 59: 1207-16 (2016)
The University of Arizona
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.
J Med Chem 59: 1140-8 (2016)
Karolinska Institutet
Recent developments of 2-aminothiazoles in medicinal chemistry.
Eur J Med Chem 109: 89-98 (2016)
Post Graduate Department of Chemistry, Sree Chaitanya College, Habra, 24 Parganas 743268, India. Electronic address: debasisdas@chemconfidence.com.
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.
J Med Chem 59: 1370-87 (2016)
GlaxoSmithKline
Dihydropyrimidine based hydrazine dihydrochloride derivatives as potent urease inhibitors.
Bioorg Chem 64: 85-96 (2016)
University of Karachi
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
J Med Chem 59: 1357-69 (2016)
GlaxoSmithKline
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat.
J Med Chem 59: 1556-64 (2016)
Epizyme
Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.
Bioorg Med Chem Lett 26: 931-5 (2016)
Eli Lilly and Company
Peptide-based inhibitors of protein-protein interactions.
Bioorg Med Chem Lett 26: 707-13 (2016)
Wroclaw University of Technology
Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
Bioorg Med Chem 24: 578-87 (2016)
Northern Kentucky University
Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2).
Bioorg Med Chem 24: 521-44 (2016)
Icahn School of Medicine at Mount Sinai
Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.
Eur J Med Chem 109: 75-88 (2016)
Sungkyunkwan University
Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study.
J Med Chem 59: 867-91 (2016)
University of Perugia
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity.
J Med Chem 59: 947-64 (2016)
University of Warwick
Targeting the Bacterial Division Protein FtsZ.
J Med Chem 59: 6975-98 (2016)
University of Wisconsin-Madison
Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants.
J Med Chem 59: 2005-24 (2016)
Pfizer Inc
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility.
J Med Chem 59: 1052-67 (2016)
Universit£ degli Studi di Siena
Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase.
Bioorg Med Chem Lett 26: 765-8 (2016)
Second Military Medical University
Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
Bioorg Med Chem Lett 26: 836-40 (2016)
University College of Pharmaceutical Sciences
One-pot green synthesis of 1,3,5-triarylpentane-1,5-dione and triarylmethane derivatives as a new class of tyrosinase inhibitors.
Bioorg Med Chem Lett 26: 795-8 (2016)
Jiangnan University
Synthesis and biological evaluation of novel 5-hydroxylaminoisoxazole derivatives as lipoxygenase inhibitors and metabolism enhancing agents.
Bioorg Med Chem 24: 712-20 (2016)
Lomonosov Moscow State University
Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors.
Bioorg Med Chem 24: 750-8 (2016)
The First Affiliated Hospital of Xi'an Jiaotong University
Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dualaVß3 anda5ß1 integrin ligands.
Bioorg Med Chem 24: 703-11 (2016)
University of Florence
Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.
Bioorg Med Chem 24: 686-92 (2016)
University of Minnesota
Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists.
Bioorg Med Chem 24: 554-69 (2016)
CNRS
Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities.
Bioorg Med Chem 24: 672-80 (2016)
Henan University
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
J Med Chem 59: 1003-20 (2016)
GlaxoSmithKline
TRPA1 channels as targets for resveratrol and related stilbenoids.
Bioorg Med Chem Lett 26: 899-902 (2016)
Sapienza University of Rome
Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
Bioorg Med Chem Lett 26: 889-93 (2016)
Institut f£r Pharmazeutische und Medizinische Chemie der Westf£lischen Wilhelms-Universit£t M£nster
Amides of non-steroidal anti-inflammatory drugs with thiomorpholine can yield hypolipidemic agents with improved anti-inflammatory activity.
Bioorg Med Chem Lett 26: 910-3 (2016)
Aristotelian University of Thessaloniki
Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors.
Bioorg Med Chem Lett 26: 1090-1096 (2016)
Genomics Institute of the Novartis Research Foundation
2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport.
Bioorg Med Chem Lett 26: 1044-7 (2016)
Vanderbilt University Medical Center
Enantiomeric 3-deaza-1',6'-isoneplanocin and its 3-bromo analogue: Synthesis by the Ullmann reaction and their antiviral properties.
Bioorg Med Chem Lett 26: 928-30 (2016)
Auburn University
The influence of 5-HT(2A) activity on a 5-HT(2C) specific in vivo assay used for early identification of multiple acting SERT and 5-HT(2C) receptor ligands.
Bioorg Med Chem Lett 26: 914-20 (2016)
Gedeon Richter Plc
Discovery and preclinical evaluation of potent, orally bioavailable, metabolically stable cyclopropylindolobenzazepine acylsulfonamides as thumb site 1 inhibitors of the hepatitis c virus NS5B RNA-dependent, RNA polymerase.
Bioorg Med Chem Lett 26: 936-40 (2016)
Bristol-Myers Squibb Pharmaceutical Research and Development
Arylpiperidines as a new class of oxidosqualene cyclase inhibitors.
Eur J Med Chem 109: 13-22 (2016)
Ludwig-Maximilians University
Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.
J Med Chem 59: 5604-21 (2016)
University of Strathclyde
Mechanism of the Flavoprotein l-Hydroxynicotine Oxidase: Kinetic Mechanism, Substrate Specificity, Reaction Product, and Roles of Active-Site Residues.
Biochemistry 55: 697-703 (2016)
University of Texas at San Antonio
Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL).
J Med Chem 59: 892-913 (2016)
University of Michigan
The Rational Design of Selective Benzoxazepin Inhibitors of thea-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326).
J Med Chem 59: 985-1002 (2016)
Genentech
Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1a receptors.
Eur J Med Chem 108: 730-40 (2016)
The University of Sydney
Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
Eur J Med Chem 108: 701-19 (2016)
University of Tours
Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC.
Eur J Med Chem 109: 1-12 (2016)
China Pharmaceutical University
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.
J Med Chem 59: 1388-409 (2016)
The Institute of Cancer Research
Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties.
J Med Chem 59: 2497-511 (2016)
AstraZeneca
4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies.
J Med Chem 59: 721-32 (2016)
Universit£ de Reims Champagne-Ardenne
Illuminating the binding interactions of galactonoamidines during the inhibition ofß-galactosidase (E. coli).
Bioorg Med Chem 24: 661-71 (2016)
University of Arkansas
Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
Bioorg Med Chem Lett 26: 959-64 (2016)
The Alexander Shulgin Research Institute
Discovery of EBI-907: A highly potent and orally active B-Raf(V600E) inhibitor for the treatment of melanoma and associated cancers.
Bioorg Med Chem Lett 26: 819-23 (2016)
Shanghai Hengrui Pharmaceutical Co., Ltd
In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells.
Bioorg Med Chem Lett 26: 1073-1079 (2016)
Kyung Hee University
Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives.
J Med Chem 59: 1116-39 (2016)
Takeda Pharmaceutical Co., Ltd
Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease.
Eur J Med Chem 108: 687-700 (2016)
University of Bras£lia
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins.
J Med Chem 59: 1634-41 (2016)
Centre National de la Recherche Scientifique (CNRS)
Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family.
J Med Chem 59: 1165-75 (2016)
Pfizer Inc
Synthesis and evaluation of a radioiodinated 4,6-diaryl-3-cyano-2-pyridinone derivative as a survivin targeting SPECT probe for tumor imaging.
Bioorg Med Chem Lett 26: 999-1004 (2016)
Nagasaki University
Identification of allosteric ERK2 inhibitors through in silico biased screening and competitive binding assay.
Bioorg Med Chem Lett 26: 955-8 (2016)
Osaka Prefecture University
Active site-directed plasmin inhibitors: Extension on the P2 residue.
Bioorg Med Chem 24: 545-53 (2016)
Kobe Gakuin University
4-Acyl Pyrrole Derivatives Yield Novel Vectors for Designing Inhibitors of the Acetyl-Lysine Recognition Site of BRD4(1).
J Med Chem 59: 1518-30 (2016)
Albert-Ludwigs-University of Freiburg
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation.
J Med Chem 59: 1565-79 (2016)
Guangzhou Institutes of Biomedicine and Health
Amorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria.
J Nat Prod 79: 2-12 (2016)
Max Planck Institute for Molecular Genetics
Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists.
Eur J Med Chem 108: 655-62 (2016)
Suven Life Sciences Ltd
Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.
Eur J Med Chem 108: 644-54 (2016)
Sun Yat-sen University
Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.
J Med Chem 59: 1648-53 (2016)
University of Oxford
A FRET-Based Assay for the Identification and Characterization of Cereblon Ligands.
J Med Chem 59: 770-4 (2016)
Max Planck Institute for Developmental Biology
Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.
J Med Chem 59: 592-608 (2016)
University of Maryland
Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.
Bioorg Med Chem Lett 26: 1016-9 (2016)
Ono Pharmaceutical Co., Ltd
Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.
Bioorg Med Chem Lett 26: 986-91 (2016)
The University of Queensland
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Eur J Med Chem 108: 623-43 (2016)
Semmelweis University
Improving selectivity of dopamine D3 receptor ligands.
Bioorg Med Chem Lett 26: 885-8 (2016)
Bioprojet-Biotech
Inhibition of guinea pig aldehyde oxidase activity by different flavonoid compounds: An in vitro study.
Bioorg Chem 64: 74-84 (2016)
Kermanshah University of Medical Sciences
(E)-1,3-diphenyl-1H-pyrazole derivatives containing O-benzyl oxime moiety as potential immunosuppressive agents: Design, synthesis, molecular docking and biological evaluation.
Eur J Med Chem 108: 586-93 (2016)
Anhui Agricultural University
Structural insights into mechanisms for inhibiting amyloidß42 aggregation by non-catechol-type flavonoids.
Bioorg Med Chem 24: 304-13 (2016)
Kyoto University
2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
Bioorg Med Chem Lett 26: 292-300 (2016)
Friedrich-Alexander-Universit£t Erlangen-N£rnberg
Development of sigma-1 (s1) receptor fluorescent ligands as versatile tools to studys1 receptors.
Eur J Med Chem 108: 577-85 (2016)
Universit£ degli Studi di Bari Aldo Moro
O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1.
Eur J Med Chem 108: 564-76 (2016)
Bryn Mawr College
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold.
Eur J Med Chem 108: 542-52 (2016)
Universit£ degli Studi di Cagliari
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors.
Eur J Med Chem 108: 529-41 (2016)
Universit£ di Trieste
Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor.
Eur J Med Chem 108: 505-28 (2016)
St. Jude Children's Research Hospital
Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
Eur J Med Chem 108: 495-504 (2016)
Shenyang Pharmaceutical University
Design, synthesis and in-vitro evaluation of novel tetrahydroquinoline carbamates as HIV-1 RT inhibitor and their antifungal activity.
Bioorg Chem 64: 66-73 (2016)
Birla Institute of Technology
Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety.
ACS Med Chem Lett 6: 1241-6 (2015)
Genentech
Affinity-Based Fluorescence Polarization Assay for High-Throughput Screening of Prolyl Hydroxylase 2 Inhibitors.
ACS Med Chem Lett 6: 1236-40 (2015)
China Pharmaceutical University
Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97.
ACS Med Chem Lett 6: 1225-30 (2015)
University of Pittsburgh
4(5)-Aryl-2-C-glucopyranosyl-imidazoles as New Nanomolar Glucose Analogue Inhibitors of Glycogen Phosphorylase.
ACS Med Chem Lett 6: 1215-9 (2015)
University of Debrecen
Dual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics.
ACS Med Chem Lett 6: 1209-14 (2015)
Vrije Universiteit Brussel
Rapid Synthesis of Boc-2',6'-dimethyl-l-tyrosine and Derivatives and Incorporation into Opioid Peptidomimetics.
ACS Med Chem Lett 6: 1199-203 (2015)
University of Michigan
Potent Triazole Bisphosphonate Inhibitor of Geranylgeranyl Diphosphate Synthase.
ACS Med Chem Lett 6: 1195-8 (2015)
University of Iowa
Discovery of Novel and Orally Bioavailable Inhibitors of PI3 Kinase Based on Indazole Substituted Morpholino-Triazines.
ACS Med Chem Lett 6: 1190-4 (2015)
Sphaera Pharma Pte. Ltd
Inhibitors of the Antiapoptotic Myeloid Cell Leukemia-1 (Mcl-1) May Provide Effective Treatment for Cancer.
ACS Med Chem Lett 6: 1171-3 (2015)
Therachem Research Medilab (India) Pvt. Ltd.
Sulfonamide Compounds as Voltage Gated Sodium Channel Modulators.
ACS Med Chem Lett 6: 1168-70 (2015)
Temple University
Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.
Bioorg Med Chem 24: 85-91 (2016)
University of Arizona
9-Benzoyl 9-deazaguanines as potent xanthine oxidase inhibitors.
Bioorg Med Chem 24: 226-31 (2016)
Universidade Estadual de Campinas
Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors.
Bioorg Med Chem 24: 207-19 (2016)
Korea Research Institute of Chemical Technology
Diarylthiophenes as inhibitors of the pore-forming protein perforin.
Bioorg Med Chem Lett 26: 355-60 (2016)
University of Auckland
Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors.
Bioorg Med Chem Lett 26: 310-4 (2016)
Korea University
A dimeric urea of the bisabolene sesquiterpene from the Okinawan marine sponge Axinyssa sp. inhibits protein tyrosine phosphatase 1B activity in Huh-7 human hepatoma cells.
Bioorg Med Chem Lett 26: 315-7 (2016)
Tohoku Pharmaceutical University
Recent Progress in Histone Demethylase Inhibitors.
J Med Chem 59: 1308-29 (2016)
University of Oxford
Discovery of Vibegron: A Potent and Selectiveß3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.
J Med Chem 59: 609-23 (2016)
Merck Research Laboratories
Exploring the role of chloro and methyl substitutions in 2-phenylthiomethyl-benzoindole derivatives for 5-LOX enzyme inhibition.
Eur J Med Chem 108: 466-75 (2016)
Second University of Naples
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry.
Eur J Med Chem 108: 455-65 (2016)
Instituto de Tecnologia em F£rmacos
Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
Eur J Med Chem 108: 444-54 (2016)
Universit£ Claude Bernard Lyon 1
Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
Eur J Med Chem 108: 436-43 (2016)
University of Wuerzburg
Design and synthesis of novel Y-shaped barbituric acid derivatives as PPAR¿ activators.
Eur J Med Chem 108: 423-35 (2016)
National Institute of Pharmaceutical Education and Research (NIPER)
Synthesis of 5-trifluoromethyl-2-sulfonylpyridine PPARß/d antagonists: Effects on the affinity and selectivity towards PPARß/d.
Bioorg Med Chem 24: 247-60 (2016)
University of Oslo
Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands.
Bioorg Med Chem 24: 191-200 (2016)
Chonnam National University
Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists.
Bioorg Med Chem Lett 26: 257-61 (2016)
Janssen Research and Development LLC
Characterization of isobutylhydroxyamides with NGF-potentiating activity from Zanthoxylum bungeanum.
Bioorg Med Chem Lett 26: 338-42 (2016)
Northwest A & F University
Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
Eur J Med Chem 108: 415-22 (2016)
Egyptian Russian University
Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for thea3ß4 nicotinic acetylcholine receptor subtype.
Eur J Med Chem 108: 392-405 (2016)
Universit£ degli Studi di Milano
Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
Eur J Med Chem 108: 381-91 (2016)
Southeast University
Straightforward and effective synthesis of¿-aminobutyric acid transporter subtype 2-selective acyl-substituted azaspiro[4.5]decanes.
Bioorg Med Chem Lett 26: 417-23 (2016)
Universit£ Catholique de Louvain
Development and structural analysis of adenosine site binding tankyrase inhibitors.
Bioorg Med Chem Lett 26: 328-33 (2016)
University of Oulu
7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.
Bioorg Med Chem Lett 26: 484-94 (2016)
Shenyang Pharmaceutical University
a-Aryl pyrrolidine sulfonamides as TRPA1 antagonists.
Bioorg Med Chem Lett 26: 495-8 (2016)
Genentech
Novel thiol-based histone deacetylase inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide scaffold as surface recognition motif: Design, synthesis and SAR study.
Bioorg Med Chem Lett 26: 375-9 (2016)
Shenyang Pharmaceutical University
8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells.
Bioorg Med Chem 24: 160-78 (2016)
New York University Abu Dhabi
Combination of 4-anilinoquinazoline, arylurea and tertiary amine moiety to discover novel anticancer agents.
Bioorg Med Chem 24: 179-90 (2016)
Xi'an Jiaotong University
Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking.
Bioorg Med Chem 24: 153-9 (2016)
Gyeongsang National University
N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.
Bioorg Med Chem 24: 130-9 (2016)
Jagiellonian University Medical College
Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors.
J Med Chem 59: 655-70 (2016)
Universidade Federal de Alfenas
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.
J Med Chem 59: 578-91 (2016)
University of Illinois at Chicago
Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.
J Med Chem 59: 157-70 (2016)
Purdue University
Discovery of potent and orally bioavailable inhibitors of Human Uric Acid Transporter 1 (hURAT1) and binding mode prediction using homology model.
Bioorg Med Chem Lett 26: 277-82 (2016)
Shanghai Hengrui Pharmaceutical Co., Ltd
Novel phenylalanine derived diamides as Factor XIa inhibitors.
Bioorg Med Chem Lett 26: 472-8 (2016)
Bristol-Myers Squibb Co.
Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes.
Bioorg Med Chem Lett 26: 424-8 (2016)
Semmelweis University
Fragment-based drug discovery of potent and selective MKK3/6 inhibitors.
Bioorg Med Chem Lett 26: 1086-9 (2016)
Takeda California Inc
Novel chromenedione derivatives displaying inhibition of protein tyrosine phosphatase 1B (PTP1B) from Flemingia philippinensis.
Bioorg Med Chem Lett 26: 318-21 (2016)
Qiqihar University
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent.
J Med Chem 59: 1501-17 (2016)
European Institute of Oncology
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance.
Sci Adv 1: (2015)
University of Oxford
Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members.
Biochemistry 55: 608-17 (2016)
University College London
Structure-Based Design and Synthesis of 3-Amino-1,5-dihydro-4H-pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 Inhibitors.
J Med Chem 59: 733-49 (2016)
Takeda Pharmaceutical Co., Ltd
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
J Med Chem 59: 1249-70 (2016)
University of Freiburg
Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.
J Med Chem 59: 707-20 (2016)
National Institute of Biological Sciences, Beijing
Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
J Med Chem 59: 671-86 (2016)
ARIAD Pharmaceuticals Inc
Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.
J Med Chem 59: 4245-56 (2016)
Istituto Italiano di Tecnologia
Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators.
J Med Chem 59: 1531-44 (2016)
Kyoto Prefectural University of Medicine
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.
J Med Chem 59: 1580-98 (2016)
University of Oxford
Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.
Eur J Med Chem 108: 334-46 (2016)
Jagiellonian University Medical College
Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase.
Eur J Med Chem 108: 322-33 (2016)
Chinese Academy of Sciences
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.
J Med Chem 59: 1599-612 (2016)
Albert-Ludwigs-University of Freiburg
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3ß Inhibitors.
J Med Chem 59: 531-44 (2016)
Alma Mater Studiorum-University of Bologna
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1.
ACS Med Chem Lett 6: 1184-1189 (2015)
University of Washington
The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
Bioorg Med Chem 24: 113-22 (2016)
University of Louisiana at Monroe
Sulfonamide inhibition studies of thea-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
Bioorg Med Chem Lett 26: 401-5 (2016)
Universit£ degli Studi di Firenze
Novel PTP1B inhibitors identified by DNA display of fragment pairs.
Bioorg Med Chem Lett 26: 1080-1085 (2016)
University of Geneva
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
Bioorg Med Chem Lett 26: 406-12 (2016)
Beni-Suef University
Identifying New Drug Targets for Potent Phospholipase D Inhibitors: Combining Sequence Alignment, Molecular Docking, and Enzyme Activity/Binding Assays.
Chem Biol Drug Des 87: 714-29 (2016)
Roxbury Community College
Chlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agents.
Bioorg Med Chem 24: 53-72 (2016)
Jagiellonian University Medical College
Molecular modeling studies, synthesis and biological evaluation of dabigatran analogues as thrombin inhibitors.
Bioorg Med Chem 24: 73-84 (2016)
Shanghai Institute of Technology
Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.
J Med Chem 59: 5131-48 (2016)
State University of New York Upstate Medical University
Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts.
Eur J Med Chem 108: 274-86 (2016)
Orchid Chemicals & Pharmaceuticals Ltd
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
J Med Chem 59: 462-73 (2016)
Universit£ degli Studi di Firenze
Late-stage optimization of a tercyclic class of S1P3-sparing, S1P1 receptor agonists.
Bioorg Med Chem Lett 26: 466-71 (2016)
Boehringer Ingelheim Pharmaceuticals Inc
Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
ACS Chem Biol 11: 1001-11 (2016)
German Cancer Research Center (DKFZ)
Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
J Med Chem 59: 545-58 (2016)
Charles University
Structure-Activity Relationship of Azaindole-Based Glucokinase Activators.
J Med Chem 59: 687-706 (2016)
Servier Research Institute of Medicinal Chemistry
Rapid Identification of Novel Inhibitors of the Human Aquaporin-1 Water Channel.
Chem Biol Drug Des 87: 794-805 (2016)
Novartis Institutes of Biomedical Research Institute
Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia.
Bioorg Med Chem Lett 26: 429-34 (2016)
Janssen Pharmaceutica NV
Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.
Chem Biol Drug Des 87: 737-46 (2016)
North-West University
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy.
J Med Chem 59: 750-5 (2016)
Eli Lilly and Company
Fluorescent sulfonamide carbonic anhydrase inhibitors incorporating 1,2,3-triazole moieties: Kinetic and X-ray crystallographic studies.
Bioorg Med Chem 24: 104-12 (2016)
Universit£ degli Studi di Firenze
Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor.
Medchemcomm 5: 1879-1886 (2014)
University of Oxford
The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains.
Medchemcomm 4: 140-144 (2013)
University of Oxford
Preparation and optimization of pyrazolo[1,5-a]pyrimidines as new potent PDE4 inhibitors.
Bioorg Med Chem Lett 26: 454-9 (2016)
Sanofi Research Center
Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.
J Med Chem 59: 1613-33 (2016)
Washington University
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer.
J Med Chem 59: 219-37 (2016)
University of Illinois at Chicago
Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors.
Bioorg Med Chem 24: 42-52 (2016)
Birla Institute of Technology & Science-Pilani
Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds.
Bioorg Med Chem 24: 20-5 (2016)
King Saud University
Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability.
Bioorg Med Chem Lett 26: 575-9 (2016)
Genentech
Design of High-Affinity Stapled Peptides To Target the Repressor Activator Protein 1 (RAP1)/Telomeric Repeat-Binding Factor 2 (TRF2) Protein-Protein Interaction in the Shelterin Complex.
J Med Chem 59: 328-34 (2016)
University of Michigan
Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure-activity relationship studies of 1,3,5-triazine analogues.
Bioorg Med Chem Lett 26: 518-23 (2016)
Thapar University
Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.
J Med Chem 59: 374-87 (2016)
Latvian Institute of Organic Synthesis
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.
Chem Biol 22: 1588-96 (2015)
Pfizer Inc
Discovery of 1,3-Diaryl-pyridones as Potent VEGFR-2 Inhibitors: Design, Synthesis, and Biological Evaluation.
Chem Biol Drug Des 87: 694-703 (2016)
East China University of Science & Technology
Multitarget opioid ligands in pain relief: New players in an old game.
Eur J Med Chem 108: 211-28 (2016)
University of Catania
Targeting quorum sensing by designing azoline derivatives to inhibit the N-hexanoyl homoserine lactone-receptor CviR: Synthesis as well as biological and theoretical evaluations.
Bioorg Med Chem 23: 7565-77 (2015)
Instituto Polit£cnico Nacional (IPN)
Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
J Med Chem 58: 9562-77 (2015)
Mayo Clinic
Studies on Aryl-Substituted Phenylalanines: Synthesis, Activity, and Different Binding Modes at AMPA Receptors.
J Med Chem 59: 448-61 (2016)
University of Copenhagen
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.
J Med Chem 59: 313-27 (2016)
Pfizer Inc
Flat SAR of P3-methylsulphonamide based small molecule legumain inhibitors.
Bioorg Med Chem Lett 26: 413-6 (2016)
Queen's University Belfast
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.
J Med Chem 59: 1545-55 (2016)
Albert-Ludwigs-University of Freiburg
Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors.
J Med Chem 59: 194-205 (2016)
Eli Lilly and Company
Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.
J Med Chem 59: 419-30 (2016)
National Health Research Institutes
Synthesis and antitumor activity evaluation of PI3K inhibitors containing 3-substituted quinazolin-4(3H)-one moiety.
Bioorg Med Chem 23: 7765-76 (2015)
Xi'an Jiaotong University
A Pyrazolo[3,4-d]pyrimidin-4-amine Derivative Containing an Isoxazole Moiety Is a Selective and Potent Inhibitor of RET Gatekeeper Mutants.
J Med Chem 59: 358-73 (2016)
Korea Institute of Science and Technology (KIST)
Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent.
J Med Chem 59: 335-57 (2016)
BioMarin Pharmaceutical Inc
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3K? Inhibitors.
J Med Chem 59: 431-47 (2016)
Amgen Inc.
Design, synthesis and biological evaluation of pyrazolyl-nitroimidazole derivatives as potential EGFR/HER-2 kinase inhibitors.
Bioorg Med Chem Lett 26: 677-83 (2016)
Nanjing University
3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1.
J Med Chem 59: 253-63 (2016)
Baylor College of Medicine
Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors.
J Med Chem 59: 238-52 (2016)
Sun Yat-sen University
1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
Bioorg Med Chem 23: 7777-84 (2015)
Universidade Federal Fluminense
Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as ?1A/1D-AR subselective antagonists for BPH.
Bioorg Med Chem 23: 7735-42 (2015)
Jinan University
Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-?-D-ribose 2'-oxidase.
Bioorg Med Chem 23: 7694-710 (2015)
AstraZeneca
Synthesis of 4-[2-(3,4-dimethoxybenzyl)cyclopentyl]-1,2-dimethoxybenzene Derivatives and Evaluations of Their Carbonic Anhydrase Isoenzymes Inhibitory Effects.
Chem Biol Drug Des 87: 594-607 (2016)
Atat£rk University
Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles.
Bioorg Med Chem Lett 26: 551-555 (2016)
Takeda Pharmaceuticals International Co.
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.
J Med Chem 59: 282-93 (2016)
National Health Research Institutes
Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp.
J Nat Prod 78: 2917-23 (2015)
Memorial Sloan-Kettering Cancer Center
Novel Microtubule-Targeting 7-Deazahypoxanthines Derived from Marine Alkaloid Rigidins with Potent in Vitro and in Vivo Anticancer Activities.
J Med Chem 59: 480-5 (2016)
Texas State University
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?
J Med Chem 59: 264-81 (2016)
University of Belgrade
An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in ß-Cell Protection.
ACS Chem Biol 11: 363-74 (2016)
Broad Institute of Harvard and MIT
Synthesis and biological activity of diisothiocyanate-derived mercapturic acids.
Bioorg Med Chem Lett 26: 667-71 (2016)
Wroclaw University of Technology
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase.
Bioorg Med Chem Lett 26: 534-9 (2016)
Genentech
Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.
Eur J Med Chem 108: 141-53 (2016)
UiT The Arctic University of Norway
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor.
Eur J Med Chem 108: 117-33 (2016)
Universit£ degli Studi di Firenze
Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Eur J Med Chem 108: 89-103 (2016)
China Pharmaceutical University
Benzimidazole derivatives as new a-glucosidase inhibitors and in silico studies.
Bioorg Chem 64: 29-36 (2016)
Universiti Teknologi MARA (UiTM)
Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1.
J Med Chem 58: 9522-34 (2015)
Gause Institute of New Antibiotics
Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents.
J Med Chem 59: 559-77 (2016)
Duke University School of Medicine
Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting theµ-Opioid Receptor.
J Med Chem 58: 9754-67 (2015)
University of Nottingham
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
J Med Chem 59: 114-31 (2016)
China Pharmaceutical University
Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5a-reductase and on cancer cell line SK-LU-1.
Bioorg Med Chem 23: 7535-42 (2015)
Universidad Nacional Aut£noma de M£xico
Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.
Bioorg Med Chem 23: 7717-27 (2015)
Yonsei University
Phenolic group on A-ring is key for dracoflavan B as a selective noncompetitive inhibitor of ?-amylase.
Bioorg Med Chem 23: 7641-9 (2015)
National University of Singapore
Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity.
Bioorg Med Chem Lett 26: 662-6 (2016)
Bristol-Myers Squibb Co.
Design and optimization of selective azaindole amide M1 positive allosteric modulators.
Bioorg Med Chem Lett 26: 650-5 (2016)
Pfizer Inc
Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a Potent and Orally Available FLT3 Kinase Inhibitor for FLT3-ITD Positive Acute Myeloid Leukemia.
J Med Chem 58: 9625-38 (2015)
Chinese Academy of Sciences
A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1a,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo.
J Med Chem 58: 9731-41 (2015)
University of Wisconsin-Madison
Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors.
Eur J Med Chem 108: 53-67 (2016)
European Institute of Oncology
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation.
Eur J Med Chem 108: 39-52 (2016)
Universit£ di Ferrara
Synthesis and evaluation of gallocyanine dyes as potential agents for the treatment of Alzheimer's disease and related neurodegenerative tauopathies.
Eur J Med Chem 108: 28-38 (2016)
Aristotle University of Thessaloniki
Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Eur J Med Chem 108: 21-7 (2016)
Fudan University
Synthesis and multiparametric evaluation of thiadiazoles and oxadiazoles as diacylglycerol acyltransferase type 1 inhibitors.
Bioorg Med Chem Lett 26: 25-32 (2016)
Sanofi-aventis R&D
Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors.
Bioorg Med Chem 23: 7685-93 (2015)
Shandong University
Discovery of the imidazole-derived GPR40 agonist AM-3189.
Bioorg Med Chem Lett 26: 15-20 (2015)
Amgen Inc
3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors.
J Med Chem 59: 4221-34 (2016)
McGill University
Avertoxins A-D, Prenyl Asteltoxin Derivatives from Aspergillus versicolor Y10, an Endophytic Fungus of Huperzia serrata.
J Nat Prod 78: 3067-70 (2015)
Fujian Normal University
Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors.
ACS Med Chem Lett 6: 1140-4 (2015)
Institute of Chemical Technology
Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment.
ACS Med Chem Lett 6: 1128-33 (2015)
Pfizer Inc
Identification of dual PPAR?/? agonists and their effects on lipid metabolism.
Bioorg Med Chem 23: 7676-84 (2015)
The University of Sydney
Addressing cytotoxicity of 1,4-biphenyl amide derivatives: Discovery of new potent and selective 17?-hydroxysteroid dehydrogenase type 2 inhibitors.
Bioorg Med Chem Lett 26: 21-4 (2016)
Saarland University
Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors.
Bioorg Med Chem Lett 26: 33-7 (2015)
Birla Institute of Technology
Identification of azabenzimidazoles as potent JAK1 selective inhibitors.
Bioorg Med Chem Lett 26: 60-7 (2015)
AstraZeneca
Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids.
Bioorg Med Chem 23: 7597-606 (2015)
McGill University
Modification of a dihydropyrrolopyrimidine phosphoinositide 3-kinase (PI3K) inhibitor to improve oral bioavailability.
Bioorg Med Chem 23: 7650-60 (2015)
Chugai Pharmaceutical Co. Ltd
Synthesis, Biological Activities, and X-ray Crystal Structural Analysis of 25-Hydroxy-25(or 26)-adamantyl-17-[20(22),23-diynyl]-21-norvitamin D Compounds.
J Med Chem 58: 9510-21 (2015)
Rikkyo University
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.
J Med Chem 58: 9546-61 (2015)
Chonnam National University
Optimization of allosteric MEK inhibitors. Part 2: Taming the sulfamide group balances compound distribution properties.
Bioorg Med Chem Lett 26: 186-93 (2015)
Bayer HealthCare AG
Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates.
Bioorg Med Chem Lett 26: 154-9 (2016)
University of Geneva
Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.
Bioorg Med Chem Lett 26: 222-7 (2016)
University of Arizona
Discovery of substituted-2,4-dimethyl-(naphthalene-4-carbonyl)amino-benzoic acid as potent and selective EP4 antagonists.
Bioorg Med Chem Lett 26: 105-9 (2016)
Eli Lilly and Company
Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities.
Bioorg Med Chem Lett 26: 51-4 (2015)
Korea University of Science and Technology
Identification of novel protein tyrosine phosphatase sigma inhibitors promoting neurite extension.
Bioorg Med Chem Lett 26: 87-93 (2016)
Chungnam National University
Hit-to-lead optimization of phenylsulfonyl hydrazides for a potent suppressor of PGE2 production: Synthesis, biological activity, and molecular docking study.
Bioorg Med Chem Lett 26: 94-9 (2015)
Kyung Hee University
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia.
Bioorg Med Chem Lett 26: 126-32 (2016)
Merck Research Laboratories
Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents.
Eur J Med Chem 107: 288-94 (2016)
Anadolu University
Extended structure-activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties.
Eur J Med Chem 107: 255-74 (2015)
Norwegian University of Science and Technology
Identification of Noncompetitive Inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.
J Med Chem 58: 9680-96 (2015)
Universit£ de Montpellier
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.
J Med Chem 58: 9773-8 (2015)
Universit£ di Napoli Federico II
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
ACS Chem Biol 11: 772-81 (2016)
University of Toronto
Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists.
Bioorg Med Chem Lett 26: 140-4 (2016)
Korea Institute of Science and Technology (KIST)
Diversification of edaravone via palladium-catalyzed hydrazine cross-coupling: Applications against protein misfolding and oligomerization of beta-amyloid.
Bioorg Med Chem Lett 26: 100-4 (2015)
Dalhousie University
Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
Bioorg Med Chem Lett 26: 72-5 (2016)
Chongqing University
Fragment-assisted hit investigation involving integrated HTS and fragment screening: Application to the identification of phosphodiesterase 10A (PDE10A) inhibitors.
Bioorg Med Chem Lett 26: 197-202 (2016)
AstraZeneca
Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11?-HSD1 inhibitors.
Bioorg Med Chem 23: 7607-17 (2015)
Universitat de Barcelona
Discovery of novel quinoline-based mTOR inhibitors via introducing intra-molecular hydrogen bonding scaffold (iMHBS): The design, synthesis and biological evaluation.
Bioorg Med Chem 23: 7585-96 (2015)
Zhejiang University
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor¿ Modulators.
J Med Chem 59: 61-81 (2016)
Goethe-University Frankfurt
Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Bioorg Chem 64: 13-20 (2016)
Government College University
Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.
J Med Chem 58: 9578-90 (2015)
Stockholm University
1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation.
Eur J Med Chem 107: 165-79 (2016)
Cairo University
Discovery of benzamides as potent human ?3 adrenergic receptor agonists.
Bioorg Med Chem Lett 26: 55-9 (2016)
Merck and Co.
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? The Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors.
J Nat Prod 78: 2867-79 (2015)
Mashhad University of Medical Sciences
Structure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase.
J Med Chem 58: 9712-21 (2015)
University of Ljubljana
Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Eur J Med Chem 107: 219-32 (2016)
Yogi Vemana University
New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
Eur J Med Chem 107: 204-18 (2016)
GLSynthesis, Inc.
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
J Med Chem 59: 5149-57 (2016)
Universit£ Clermont Auvergne
Synthesis and comparison of the biological activity of monocyclic phosphonate, difluorophosphonate and phosphate analogs of the natural AChE inhibitor cyclophostin.
Bioorg Med Chem 23: 7529-34 (2015)
University of Missouri-St. Louis
A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities.
Bioorg Med Chem 23: 7543-64 (2015)
Georgia Institute of Technology
2,30-Bis(10H-indole) heterocycles: New p53/MDM2/MDMX antagonists.
Bioorg Med Chem Lett 25: 5661-6 (2015)
University of Groningen
Comprehensive Analysis of Structure-Activity Relationships of ?-Ketoheterocycles as sn-1-Diacylglycerol Lipase ? Inhibitors.
J Med Chem 58: 9742-53 (2015)
Leiden University
1,9-seco-Bicyclic Polyprenylated Acylphloroglucinols from Hypericum uralum.
J Nat Prod 78: 3075-9 (2015)
Chinese Academy of Sciences
Design of ?7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.
Eur J Med Chem 107: 153-64 (2016)
Universite Orleans
An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.
J Med Chem 58: 9309-33 (2015)
University of Sheffield
Development of 2-(Substituted Benzylamino)-4-Methyl-1, 3-Thiazole-5-Carboxylic Acid Derivatives as Xanthine Oxidase Inhibitors and Free Radical Scavengers.
Chem Biol Drug Des 87: 508-16 (2016)
Jamia Hamdard
Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.
Eur J Med Chem 107: 119-32 (2016)
University of Eastern Finland
Arthroamide, a Cyclic Depsipeptide with Quorum Sensing Inhibitory Activity from Arthrobacter sp.
J Nat Prod 78: 2827-31 (2015)
Toyama Prefectural University
Discovery and SAR of Novel and Selective Inhibitors of Urokinase Plasminogen Activator (uPA) with an Imidazo[1,2-a]pyridine Scaffold.
J Med Chem 58: 9238-57 (2015)
University of Antwerp (UA)
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
J Med Chem 59: 1271-98 (2016)
Genentech
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.
J Med Chem 58: 9273-86 (2015)
Novartis Institutes for BioMedical Research
Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation.
J Med Chem 58: 9296-9308 (2015)
Dana-Farber Cancer Institute
Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia.
J Med Chem 58: 9768-72 (2015)
Eli Lilly and Company
Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.
J Med Chem 58: 9287-95 (2015)
Janssen Pharmaceutica N.V.
Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083).
J Med Chem 58: 9480-97 (2015)
Cleave Biosciences Inc.
Efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc) and sp(2)-iminosugar conjugates: Novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme.
Eur J Med Chem 121: 926-938 (2016)
The Barcelona Institute of Science and Technology
Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition.
Bioorg Med Chem Lett 25: 5682-6 (2015)
East China University of Science and Technology
Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines.
Eur J Med Chem 107: 97-108 (2015)
Institute of Radiopharmaceutical Cancer Research
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Eur J Med Chem 107: 63-81 (2015)
Central University
Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy.
Eur J Med Chem 107: 48-62 (2016)
China Pharmaceutical University
Development of Alkyne-Containing Pyrazolopyrimidines To Overcome Drug Resistance of Bcr-Abl Kinase.
J Med Chem 58: 9228-37 (2015)
University of Southern California
Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors.
J Med Chem 58: 9345-53 (2015)
Merck & Co., Inc.
Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Bioorg Chem 64: 1-12 (2016)
Beni-Suef University
Novel Hits in the Correction of ?F508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein: Synthesis, Pharmacological, and ADME Evaluation of Tetrahydropyrido[4,3-d]pyrimidines for the Potential Treatment of Cystic Fibrosis.
J Med Chem 58: 9697-711 (2015)
Siena Biotech S.p.A.
Benzoxazolone Carboxamides as Potent Acid Ceramidase Inhibitors: Synthesis and Structure-Activity Relationship (SAR) Studies.
J Med Chem 58: 9258-72 (2015)
Fondazione Istituto Italiano di Tecnologia
Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship.
Eur J Med Chem 107: 1-11 (2016)
CSIR-Indian Institute of Integrative Medicine
Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors.
Bioorg Med Chem 23: 7359-65 (2015)
Shandong University
Microwave-assisted solid-phase synthesis of side-chain to side-chain lactam-bridge cyclic peptides.
Bioorg Med Chem Lett 25: 5708-11 (2015)
University of Minnesota
Novel ?-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway.
J Med Chem 58: 9214-27 (2015)
China Pharmaceutical University
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective.
J Med Chem 59: 3593-608 (2016)
University of Edinburgh
Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure-Activity Relationship Study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson's Disease.
J Med Chem 58: 9179-95 (2015)
Wayne State University
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.
Cancer Res 75: 5106-5119 (2015)
University of Oxford
Meroterpenoids from a Tropical Dysidea sp. Sponge.
J Nat Prod 78: 2814-21 (2015)
Seoul National University
Triazole double-headed ribonucleosides as inhibitors of eosinophil derived neurotoxin.
Bioorg Chem 63: 152-65 (2015)
University of Thessaly
Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase-Glucokinase Regulatory Protein (GK-GKRP) Binding: Strategic Use of a N ? S (nN ? ?*S-X) Interaction for Conformational Constraint.
J Med Chem 58: 9663-79 (2015)
Amgen
Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi.
Bioorg Med Chem 23: 7478-86 (2015)
Universidade Federal de Pernambuco
Design and synthesis of an in vivo-efficacious PIM3 kinase inhibitor as a candidate anti-pancreatic cancer agent.
Bioorg Med Chem Lett 25: 5687-93 (2015)
The University of Tokyo
2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors.
Bioorg Chem 63: 142-51 (2015)
University of Karachi
Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
Eur J Med Chem 106: 180-93 (2015)
Gwangju Institute of Science and Technology (GIST)
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
Bioorg Med Chem Lett 25: 5787-91 (2015)
Beni-Suef University
Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering.
Bioorg Med Chem Lett 25: 5743-7 (2015)
AstraZeneca
Structure-activity-relationship of amide and sulfonamide analogs of omarigliptin.
Bioorg Med Chem Lett 25: 5767-71 (2015)
Merck Research Laboratories
Identification and activity of inhibitors of the essential nematode-specific metalloprotease DPY-31.
Bioorg Med Chem Lett 25: 5752-5 (2015)
University of Glasgow
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.
Bioorg Med Chem Lett 25: 5720-5 (2015)
Corcept Therapeutics
Discovery of bis-aryl urea derivatives as potent and selective Limk inhibitors: Exploring Limk1 activity and Limk1/ROCK2 selectivity through a combined computational study.
Bioorg Med Chem 23: 7464-77 (2015)
Shanghai Institute of Technology
Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase.
Eur J Med Chem 106: 157-66 (2015)
Kyungpook National University
Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
Eur J Med Chem 106: 144-56 (2015)
Novartis Institute for Tropical Diseases
Novel orally active inhibitors of ?-1,3-glucan synthesis derived from enfumafungin.
Bioorg Med Chem Lett 25: 5813-8 (2015)
Merck Research Laboratories
Synthesis, biological activity evaluation and molecular docking studies of novel coumarin substituted thiazolyl-3-aryl-pyrazole-4-carbaldehydes.
Bioorg Med Chem Lett 25: 5797-803 (2015)
National Institute of Technology
Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects.
J Med Chem 58: 9382-94 (2015)
Novartis Institutes for BioMedical Research
Resveratrol-Related Polymethoxystilbene Glycosides: Synthesis, Antiproliferative Activity, and Glycosidase Inhibition.
J Nat Prod 78: 2675-83 (2015)
Universit£ degli Studi di Catania
Design, synthesis and antithrombotic evaluation of novel dabigatran etexilate analogs, a new series of non-peptides thrombin inhibitors.
Bioorg Med Chem 23: 7405-16 (2015)
China Pharmaceutical University
Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.
Eur J Med Chem 106: 120-31 (2015)
Kuwait University
Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.
J Med Chem 58: 8868-76 (2015)
Aarhus University
Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives.
Bioorg Med Chem 23: 7353-8 (2015)
Gebze Technical University
Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition.
Bioorg Med Chem Lett 25: 5792-6 (2015)
Eisai Limited
Benzo[7]annulene-based GluN2B selective NMDA receptor antagonists: Surprising effect of a nitro group in 2-position.
Bioorg Med Chem Lett 25: 5748-51 (2015)
University Munster
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
J Nat Prod 78: 2666-74 (2015)
University of Hradec Kralove
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).
J Med Chem 59: 44-60 (2016)
Dalhousie University
Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells.
Bioorg Med Chem 23: 7313-23 (2015)
Universit£ Clermont Auvergne
Synthesis of novel benzohydrazone-oxadiazole hybrids asß-glucuronidase inhibitors and molecular modeling studies.
Bioorg Med Chem 23: 7394-404 (2015)
Universiti Teknologi MARA (UiTM)
Synthesis and biological evaluation of di-aryl urea derivatives as c-Kit inhibitors.
Bioorg Med Chem 23: 7340-7 (2015)
Univ. Lille
Catecholic amides as potential selective phosphodiesterase 4D inhibitors: Design, synthesis, pharmacological evaluation and structure-activity relationships.
Bioorg Med Chem 23: 7332-9 (2015)
Southern Medical University
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4.
Bioorg Med Chem Lett 25: 5546-50 (2015)
Amgen Inc.
Inhibitory kinetics of novel 2,3-dihydro-1H-inden-1-one chalcone-like derivatives on mushroom tyrosinase.
Bioorg Med Chem Lett 25: 5495-9 (2015)
University of Technology Sydney
A novel class of negative allosteric modulators of NMDA receptor function.
Bioorg Med Chem Lett 25: 5583-8 (2015)
Emory University
A selective delta opioid receptor antagonist based on a stilbene core.
Bioorg Med Chem Lett 25: 5532-5 (2015)
The University of Iowa
Anion and sulfonamide inhibition studies of an ?-carbonic anhydrase from the Antarctic hemoglobinless fish Chionodraco hamatus.
Bioorg Med Chem Lett 25: 5485-9 (2015)
Universit£ degli Studi di Firenze
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacyµ-Opioid Receptor (MOR) Agonists/d-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
J Med Chem 58: 8952-69 (2015)
University of Michigan
Development of a potent and selective cell penetrant Legumain inhibitor.
Bioorg Med Chem Lett 25: 5642-5 (2015)
Queen's University Belfast
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs).
Bioorg Med Chem Lett 25: 5555-60 (2015)
Novartis Institutes for BioMedical Research
Potent complement C3a receptor agonists derived from oxazole amino acids: Structure-activity relationships.
Bioorg Med Chem Lett 25: 5604-8 (2015)
The University of Queensland
The use of porcupine inhibitors to target Wnt-driven cancers.
Bioorg Med Chem Lett 25: 5472-6 (2015)
Experimental Therapeutics Centre
Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
Bioorg Med Chem 23: 7264-73 (2015)
Brookhaven National Laboratory
Synthesis of 4-thiazolidinone analogs as potent in vitro anti-urease agents.
Bioorg Chem 63: 123-31 (2015)
Hazara University
Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.
Bioorg Med Chem Lett 25: 5636-41 (2015)
Balikesir University
1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
Bioorg Med Chem Lett 25: 5514-9 (2015)
University of California Davis
Synthesis and biological evaluation of negative allosteric modulators of the Kv11.1(hERG) channel.
Eur J Med Chem 106: 50-9 (2015)
Leiden University
Synthesis, Antifolate and Anticancer Activities of N(5) -Substituted 8,10-Dideazatetrahydrofolate Analogues.
Chem Biol Drug Des 87: 444-54 (2016)
Peking University
Spiroindole Alkaloids and Spiroditerpenoids from Aspergillus duricaulis and Their Potential Neuroprotective Effects.
J Nat Prod 78: 2572-9 (2015)
Korea University
Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.
J Med Chem 58: 8938-51 (2015)
University of Copenhagen
Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
Bioorg Med Chem 23: 7274-81 (2015)
Showa Pharmaceutical University
Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer's disease.
Bioorg Med Chem Lett 25: 5576-82 (2015)
Ataturk University
Highly functionalized tetrahydropyridines are cytotoxic and selective inhibitors of human puromycin sensitive aminopeptidase.
Eur J Med Chem 106: 26-33 (2015)
CSIR-Indian Institute of Chemical Technology
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines.
Eur J Med Chem 106: 15-25 (2015)
Universit£ de Lille
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges.
J Med Chem 59: 3579-92 (2016)
Sanofi-Aventis Deutschland GmbH
Ethynylphenyl carbonates and carbamates as dual-action acetylcholinesterase inhibitors and anti-inflammatory agents.
Bioorg Med Chem Lett 25: 5609-12 (2015)
Lehigh University
Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design.
J Med Chem 59: 2879-93 (2016)
Maastricht University
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends.
J Med Chem 59: 2849-78 (2016)
Shandong University
Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders.
J Med Chem 58: 9154-70 (2015)
AbbVie Bioresearch Center
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases.
J Med Chem 58: 8513-28 (2015)
Pfizer Inc
Synthesis of natural phaeosphaeride A derivatives and an in vitro evaluation of their anti-cancer potential.
Bioorg Med Chem Lett 25: 5566-9 (2015)
Research Institute of Hygiene
Discovery ofa-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
Bioorg Med Chem Lett 25: 5625-31 (2015)
Dongguk University
Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
Bioorg Med Chem Lett 25: 5619-24 (2015)
Nagoya City University
Synthesis of potent urease inhibitors based on disulfide scaffold and their molecular docking studies.
Bioorg Med Chem 23: 7211-8 (2015)
Universiti Teknologi MARA (UiTM)
Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
Bioorg Med Chem 23: 7199-210 (2015)
Ehime University
Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity.
J Med Chem 58: 8970-84 (2015)
Rice University
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies.
J Med Chem 58: 8373-86 (2015)
Novartis Institutes for Biomedical Research
Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
Eur J Med Chem 105: 289-96 (2015)
University of Groningen
Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity.
J Med Chem 58: 8985-9003 (2015)
University Hospital Hradec Kralove
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
J Med Chem 58: 8713-22 (2015)
University of Cape Town
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials.
J Med Chem 59: 3609-34 (2016)
Universit£ di Siena
Structural Elucidation of a Small Molecule Inhibitor of Protein Disulfide Isomerase.
ACS Med Chem Lett 6: 966-971 (2015)
Columbia University
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
Eur J Med Chem 105: 274-88 (2015)
University of Pisa
Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters.
Bioorg Med Chem 23: 7181-8 (2015)
Universit£ degli Studi di Firenze
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
Bioorg Med Chem 23: 7219-25 (2015)
Aristotle University of Thessaloniki
Macrocyclic prolinyl acyl guanidines as inhibitors ofß-secretase (BACE).
Bioorg Med Chem Lett 25: 5040-7 (2015)
Bristol-Myers Squibb Co.
Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors.
J Med Chem 58: 8564-72 (2015)
Sapienza University of Rome
Iminothiazoline-Sulfonamide Hybrids as Jack Bean Urease Inhibitors; Synthesis, Kinetic Mechanism and Computational Molecular Modeling.
Chem Biol Drug Des 87: 434-43 (2016)
Quaid-i-Azam University
Development of hydroxylated naphthylchalcones as polyphenol oxidase inhibitors: Synthesis, biochemistry and molecular docking studies.
Bioorg Chem 63: 116-22 (2015)
University of Technology Sydney
Evaluation of Improved Glycogen Synthase Kinase-3a Inhibitors in Models of Acute Myeloid Leukemia.
J Med Chem 58: 8907-19 (2015)
Technische Universit£t Darmstadt
Identification ofß-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma.
J Med Chem 58: 8491-502 (2015)
Institute of Basic Science (IBS)
Discovery of a Novel, Potent Spirocyclic Series of¿-Secretase Inhibitors.
J Med Chem 58: 8806-17 (2015)
Merck Research Laboratories
Design and synthesis of a novel 2-oxindole scaffold as a highly potent and brain-penetrant phosphodiesterase 10A inhibitor.
Bioorg Med Chem 23: 7138-49 (2015)
Takeda Pharmaceutical Co., Ltd
Muscarinic acetylcholine receptor binding affinities of pethidine analogs.
Bioorg Med Chem Lett 25: 5032-5 (2015)
University of Kentucky
Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
J Med Chem 58: 8723-33 (2015)
University of Minnesota
Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: introduction of an additional carboxyl group at the C-2 position of quinoline.
Eur J Med Chem 105: 145-55 (2015)
China Pharmaceutical University
Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.
J Med Chem 58: 8783-95 (2015)
The University of Kansas
Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators.
J Med Chem 58: 9498-509 (2015)
Case Western Reserve University
Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents.
ACS Med Chem Lett 6: 1086-90 (2015)
Guangzhou Institutes of Biomedicine and Health
Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.
ACS Med Chem Lett 6: 1080-5 (2015)
Cubist Pharmaceuticals Inc
Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.
ACS Med Chem Lett 6: 1075-9 (2015)
Yale University
Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors.
ACS Med Chem Lett 6: 1065-70 (2015)
University of Delhi
Thioxo-dihydroquinazolin-one Compounds as Novel Inhibitors of Myeloperoxidase.
ACS Med Chem Lett 6: 1047-52 (2015)
Emory University
5-Aryl-1-imino-1-oxo-[1,2,4]thiadiazines.
ACS Med Chem Lett 6: 1031-4 (2015)
Temple University
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
J Med Chem 58: 8920-37 (2015)
Angelini S.p.A.
Synthesis and pharmacological evaluation of piperidine (piperazine)-substituted benzoxazole derivatives as multi-target antipsychotics.
Bioorg Med Chem Lett 25: 5299-305 (2015)
Huazhong University of Science and Technology
Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-ß type I receptor kinase.
Bioorg Med Chem Lett 25: 5228-31 (2015)
Ewha Womans University
Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria.
Bioorg Med Chem Lett 25: 5067-71 (2015)
Inter American University of Puerto Rico
Constituents of the seeds of Cassia tora with inhibitory activity on soluble expoxide hydrolease.
Bioorg Med Chem Lett 25: 5097-101 (2015)
Chungnam National University
Design, synthesis and biological activity of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists.
Bioorg Med Chem 23: 7158-64 (2015)
China Pharmaceutical University
New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation.
Bioorg Med Chem 23: 6785-93 (2015)
Ronzoni Institute for Chemical and Biochem. Research
Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.
Bioorg Med Chem 23: 7079-88 (2015)
Qilu University of Technology
Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
Bioorg Med Chem 23: 6993-9 (2015)
University of North Carolina at Greensboro
Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors.
J Med Chem 58: 8529-41 (2015)
Chinese Academy of Sciences
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.
Eur J Med Chem 105: 120-37 (2015)
Universitat de Barcelona
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
Eur J Med Chem 105: 80-105 (2015)
Universit£ Fran£ois-Rabelais de Tours
Discovery of Novel Inhibitor Scaffolds against the Metallo-ß-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening.
J Med Chem 58: 8671-82 (2015)
UiT The Arctic University of Norway
Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 1: SAR of modifications to the central aryl core.
Bioorg Med Chem Lett 25: 5107-10 (2015)
Vanderbilt University Medical Center
Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: design, synthesis, and structure-activity relationship study.
Eur J Med Chem 105: 39-56 (2015)
Chinese Academy of Sciences
Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators.
Bioorg Med Chem Lett 25: 5115-20 (2015)
Vanderbilt University Medical Center
Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: Design, synthesis, kinase assay, cell-based assay, and molecular docking.
Bioorg Med Chem Lett 25: 5147-54 (2015)
Korea University of Science and Technology (UST)
Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase.
Bioorg Med Chem Lett 25: 5137-41 (2015)
China Pharmaceutical University
Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT(2A) receptor.
Bioorg Med Chem Lett 25: 5102-6 (2015)
City University of New York
Synthetic, structural mimetics of the ?-hairpin flap of HIV-1 protease inhibit enzyme function.
Bioorg Med Chem 23: 7095-109 (2015)
University of Maryland
Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
Bioorg Med Chem 23: 6844-54 (2015)
Seoul National University
Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease.
J Med Chem 58: 8616-37 (2015)
Sun Yat-sen University
Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation.
Eur J Med Chem 121: 864-879 (2016)
Okayama University
Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
Bioorg Med Chem Lett 25: 5121-6 (2015)
Pfizer Inc
Design and synthesis of aloe-emodin derivatives as potent anti-tyrosinase, antibacterial and anti-inflammatory agents.
Bioorg Med Chem Lett 25: 5142-6 (2015)
Shaoyang University
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
Eur J Med Chem 105: 1-38 (2015)
The M. S. University of Baroda
Antibacterial Prenylated Acylphloroglucinols from Psorothamnus fremontii.
J Nat Prod 78: 2748-53 (2015)
China Pharmaceutical University
Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b.
ACS Chem Biol 10: 2884-90 (2015)
University of Leipzig
Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo.
J Med Chem 58: 8683-93 (2015)
University of Glasgow
Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
J Med Chem 58: 8694-712 (2015)
Northwestern University
N(?)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.
J Med Chem 58: 8834-49 (2015)
CNRS/IPBS (Institut de Pharmacologie et Biologie Structurale)
Discovery of Novel Multifunctional Ligands with ?/? Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.
J Med Chem 58: 8573-83 (2015)
University of Arizona
Computational Tools To Model Halogen Bonds in Medicinal Chemistry.
J Med Chem 59: 1655-70 (2016)
Colorado State University
Influence of polar side chains modifications on the dual enkephalinase inhibitory activity and conformation of human opiorphin, a pain perception related peptide.
Bioorg Med Chem Lett 25: 5190-3 (2015)
Institute of Advanced Chemistry of Catalonia (IQAC-CSIC)
Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR development.
Bioorg Med Chem Lett 25: 5172-7 (2015)
AstraZeneca
2-Aminopyrimidines as dual adenosine A1/A2A antagonists.
Eur J Med Chem 104: 177-88 (2015)
North-West University
Synthesis of novel compounds containing morpholine and 5(4H)-oxazolone rings as potent tyrosinase inhibitors.
Bioorg Med Chem 23: 7089-94 (2015)
Payame Noor University (PNU)
Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
Bioorg Med Chem 23: 6974-92 (2015)
Baylor University
First Demonstration of Positive Allosteric-like Modulation at the Human Wild Type Translocator Protein (TSPO).
J Med Chem 58: 8743-9 (2015)
University of New South Wales
Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.
J Med Chem 58: 8413-26 (2015)
Hoffmann-La Roche, Inc.
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.
J Med Chem 58: 8503-12 (2015)
Cubist Pharmaceuticals Inc
Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors.
Bioorg Med Chem Lett 25: 5258-64 (2015)
Genentech
Cembranoids from the Gum Resin of Boswellia carterii as Potential Antiulcerative Colitis Agents.
J Nat Prod 78: 2322-31 (2015)
Chinese Academy of Medical Sciences and Peking Union Medical College
Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors.
Bioorg Med Chem Lett 25: 5111-4 (2015)
Emory University
Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
Chem Biol 22: 1347-61 (2015)
Aston University
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study.
J Med Chem 58: 8877-95 (2015)
Argenta Discovery Ltd.
Isomeric methoxy analogs of nimesulide for development of brain cyclooxygense-2 (COX-2)-targeted imaging agents: Synthesis, in vitro COX-2-inhibitory potency, and cellular transport properties.
Bioorg Med Chem 23: 6807-14 (2015)
Tohoku Pharmaceutical University
Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
Bioorg Med Chem 23: 6855-68 (2015)
Soochow University
Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity.
Bioorg Med Chem 23: 7000-6 (2015)
GlaxoSmithKline
Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
Bioorg Med Chem Lett 25: 5212-6 (2015)
China Pharmaceutical University
Exploration of labeling by near infrared dyes of the polyproline linker for bivalent-type CXCR4 ligands.
Bioorg Med Chem 23: 6967-73 (2015)
Tokyo Medical and Dental University
Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amine.
Eur J Med Chem 104: 139-47 (2015)
First Affiliated Hospital of Xi'an Jiaotong University
Synthesis of dihydropyrimidine ?,?-diketobutanoic acid derivatives targeting HIV integrase.
Eur J Med Chem 104: 127-38 (2015)
Univ. Orl£ans et CNRS
Novel hydrazone moiety-bearing aminopyrimidines as selective inhibitors of epidermal growth factor receptor T790M mutant.
Eur J Med Chem 104: 115-26 (2015)
Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast a-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Bioorg Chem 63: 64-71 (2015)
GC University
Optimization of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for peptides and its use in a structure-activity relationship study of a class B GPCR ligand.
Eur J Med Chem 104: 106-14 (2015)
Universit£ du Qu£bec
Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.
J Med Chem 58: 8427-43 (2015)
Bar-Ilan University
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5.
Bioorg Med Chem 23: 7024-34 (2015)
Universit£ degli Studi di Cagliari
Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer.
J Med Chem 59: 1455-70 (2016)
Sichuan University
Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking.
J Med Chem 58: 8285-91 (2015)
Bioinformatics Institute (BII)
Discovery of wrightiadione as a novel template for the TrkA kinase inhibitors.
Bioorg Med Chem Lett 25: 5186-9 (2015)
Institute for Basic Science (IBS)
Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Bioorg Chem 63: 58-63 (2015)
Quaid-i-Azam University
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
Nat Chem Biol 11: 878-86 (2015)
Albert Einstein College of Medicine
Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of ?-amyloid plaques by positron emission tomography.
Eur J Med Chem 104: 86-96 (2015)
Beijing Normal University
Mutational mapping of the transmembrane binding site of the G-protein coupled receptor TGR5 and binding mode prediction of TGR5 agonists.
Eur J Med Chem 104: 57-72 (2015)
Heinrich Heine University
Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.
Bioorg Med Chem 23: 7015-23 (2015)
University of Athens
Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists.
Bioorg Med Chem Lett 25: 5291-4 (2015)
Merck Research Laboratory
A fragment of the Escherichia coli ClpB heat-shock protein is a micromolar melanocortin 1 receptor agonist.
Bioorg Med Chem Lett 25: 5306-8 (2015)
University of Minnesota
Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of a-glucosidases.
Bioorg Chem 63: 36-44 (2015)
Universiti Teknologi MARA
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation.
Bioorg Med Chem 23: 7053-60 (2015)
University of Messina
Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
Bioorg Med Chem 23: 6955-66 (2015)
Universit£ degli Studi di Firenze
5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expression.
Bioorg Med Chem 23: 7069-78 (2015)
Sookmyung Women's University
Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.
Bioorg Med Chem 23: 7061-8 (2015)
Georgia State University
Monoamine oxidase inhibitory activities of heterocyclic chalcones.
Bioorg Med Chem Lett 25: 5270-6 (2015)
North-West University
Effects of alkyl side chains and terminal hydrophilicity on vitamin D receptor (VDR) agonistic activity based on the diphenylpentane skeleton.
Bioorg Med Chem Lett 25: 5362-6 (2015)
National Institute of Health Sciences
Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12).
J Med Chem 58: 8182-99 (2015)
WuXi AppTec Co., Ltd.
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists ors1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
J Med Chem 58: 8601-15 (2015)
Universit£ di Camerino
Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate.
J Med Chem 58: 8584-600 (2015)
Washington University
Identification of a molecular target of kurahyne, an apoptosis-inducing lipopeptide from marine cyanobacterial assemblages.
Bioorg Med Chem Lett 25: 5295-8 (2015)
Keio University
Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents.
Bioorg Med Chem Lett 25: 5281-5 (2015)
Manipal College of Pharmaceutical Sciences
Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
Bioorg Med Chem Lett 25: 5449-53 (2015)
Sichuan University
Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M(1) and M(4) muscarinic acetylcholine receptors agonists.
Bioorg Med Chem Lett 25: 5357-61 (2015)
Sumitomo Dainippon Pharma Co., Ltd
Synthesis, Biological Evaluation, and Molecular Docking of (R)-2-((8-(3-aminopiperidin-1-yl)-3-methyl-7-(3-methylbut-2-en-1-yl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzonitrile as Dipeptidyl Peptidase IV Inhibitors.
Chem Biol Drug Des 87: 290-5 (2016)
West China Hospital
Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics
J Med Chem 58: 7959-71 (2015)
Vanderbilt University
Protostane Triterpenoids from the Rhizome of Alisma orientale Exhibit Inhibitory Effects on Human Carboxylesterase 2.
J Nat Prod 78: 2372-80 (2015)
Liaoning University of Traditional Chinese Medicine
Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
Bioorg Med Chem 23: 6573-80 (2015)
Dumlupinar University
Inhibiting the Inflammasome: A Chemical Perspective.
J Med Chem 59: 1691-710 (2016)
The University of Manchester
Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors.
Bioorg Med Chem Lett 25: 5265-9 (2015)
Shandong University
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors.
Bioorg Med Chem Lett 25: 5309-14 (2015)
Aurigene Discovery Technologies Limited
Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists.
J Med Chem 58: 8292-308 (2015)
Glenmark Research Centre
Design, synthesis and structure-activity relationship studies of novel phenoxyacetamide-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
Bioorg Med Chem 23: 6666-72 (2015)
China Pharmaceutical University
Structure-Affinity Relationship Analysis of Selective FKBP51 Ligands.
J Med Chem 58: 7796-806 (2015)
Max Planck Institute of Psychiatry
Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity.
J Med Chem 58: 7991-8010 (2015)
University of Padova
Harnessing Enzymatic Promiscuity in Myxochelin Biosynthesis for the Production of 5-Lipoxygenase Inhibitors.
Chembiochem 16: 2445-50 (2015)
Hans Knöll Institute
Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
Eur J Med Chem 103: 600-14 (2015)
Georgia Institute of Technology
Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylase.
Bioorg Med Chem Lett 25: 5352-6 (2015)
Pfizer Inc
Conformationally restricted¿-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
Bioorg Med Chem Lett 25: 5326-30 (2015)
Mercachem
Nitrogenated honokiol derivatives allosterically modulate GABAA receptors and act as strong partial agonists.
Bioorg Med Chem 23: 6757-62 (2015)
University of Graz
Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII.
Eur J Med Chem 103: 583-93 (2015)
Egyptian Russian University
Diethylstilbestrol-scaffold-based pregnane X receptor modulators.
Eur J Med Chem 103: 551-62 (2015)
University of Ljubljana
An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis.
Eur J Med Chem 103: 539-50 (2015)
University of South Australia
Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist.
J Med Chem 58: 8128-40 (2015)
AstraZeneca
Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
J Med Chem 58: 7972-90 (2015)
Peking University
Design, synthesis, and evaluation of new endomorphin analogs with enhanced central antinociception after peripheral administration.
Bioorg Med Chem Lett 25: 5393-7 (2015)
Lanzhou University
Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications.
Bioorg Med Chem Lett 25: 5384-8 (2015)
Merck Research Laboratories
Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).
Bioorg Med Chem Lett 25: 5402-8 (2015)
Merck Research Laboratories
Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus Monkeys.
J Med Chem 58: 8054-65 (2015)
Roche Pharma Research and Early Development (pRED)
Evaluation of 2-indolcarbohydrazones as potent a-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions.
Bioorg Chem 63: 24-35 (2015)
Universiti Teknologi MARA (UiTM)
1-(4-Methane(amino)sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potential anti-inflammatory agents.
Bioorg Chem 63: 13-23 (2015)
Beni-Suef University
Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.
Eur J Med Chem 103: 473-87 (2015)
Beijing Institute of Technology
Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors.
ACS Med Chem Lett 6: 1019-24 (2015)
Hoffmann-La Roche Inc.
Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor.
ACS Med Chem Lett 6: 1015-8 (2015)
Janssen Research and Development LLC
Structure-Guided Design of Novel l-Cysteine Derivatives as Potent KSP Inhibitors.
ACS Med Chem Lett 6: 1004-9 (2015)
University of Shizuoka
Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPAR? Antagonists.
ACS Med Chem Lett 6: 998-1003 (2015)
The Scripps Research Institute
Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors.
ACS Med Chem Lett 6: 987-92 (2015)
Amgen Inc
Identification of Bidentate Salicylic Acid Inhibitors of PTP1B.
ACS Med Chem Lett 6: 982-6 (2015)
University of Toronto Mississauga
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma.
ACS Med Chem Lett 6: 961-5 (2015)
Novartis Institutes for BioMedical Research
RORc Modulators for the Treatment of Autoimmune Diseases.
ACS Med Chem Lett 6: 958-60 (2015)
Therachem Research Medilab (India) Pvt. Ltd.
Nav1.7 Inhibitors: Potential Effective Therapy for the Treatment of Chronic Pain.
ACS Med Chem Lett 6: 956-7 (2015)
Therachem Research Medilab (India) Pvt. Ltd.
Kynurenine Monooxygenase (KMO) Inhibitors for the Treatment of Acute Pancreatitis and Neurodegenerative Disorders.
ACS Med Chem Lett 6: 954-5 (2015)
Therachem Research Medilab (India) Pvt. Ltd.
From carbohydrates to drug-like fragments: Rational development of novela-amylase inhibitors.
Bioorg Med Chem 23: 6725-32 (2015)
Freie Universit£t Berlin
Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents.
Biochemistry 54: 6514-24 (2015)
Argonne National Laboratory
Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1? Inhibition.
J Med Chem 58: 7659-71 (2015)
Duke University
Improving the Selectivity of Engineered Protease Inhibitors: Optimizing the P2 Prime Residue Using a Versatile Cyclic Peptide Library.
J Med Chem 58: 8257-68 (2015)
Queensland University of Technology
Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P1 Agonists.
J Med Chem 58: 8236-56 (2015)
GlaxoSmithKline
1,3,7-Triethyl-substituted xanthines--possess nanomolar affinity for the adenosine A1 receptor.
Bioorg Med Chem 23: 6641-9 (2015)
North-West University
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.
ACS Chem Biol 10: 2687-96 (2015)
Dana-Farber Cancer Institute Inc
Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.
J Med Chem 58: 8166-81 (2015)
Shanghai University
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.
J Med Chem 59: 810-40 (2016)
University of Minnesota
Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.
Bioorg Med Chem 23: 6632-40 (2015)
Shandong University
Rhododendrol glycosides as stereospecific tyrosinase inhibitors.
Bioorg Med Chem 23: 6650-8 (2015)
Tokyo University of Agriculture and Technology
Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studies.
Bioorg Med Chem Lett 25: 4412-8 (2015)
Bristol-Myers Squibb Research and Development
Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.
Bioorg Med Chem Lett 25: 4405-11 (2015)
Virginia Tech
A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities.
Bioorg Med Chem 23: 6587-93 (2015)
Wuhan Institute of Technology
Design, synthesis and pharmacological evaluation of pyrimidobenzothiazole-3-carboxylate derivatives as selective L-type calcium channel blockers.
Bioorg Med Chem 23: 6689-713 (2015)
Rashtrasant Tukadoji Maharaj Nagpur University
Discovery of novel S1P2 antagonists. Part 2: Improving the profile of a series of 1,3-bis(aryloxy)benzene derivatives.
Bioorg Med Chem Lett 25: 4387-92 (2015)
Ono Pharmaceutical Co., Ltd
Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors.
Bioorg Med Chem Lett 25: 4441-6 (2015)
Kangwon National University
Converting maslinic acid into an effective inhibitor of acylcholinesterases.
Eur J Med Chem 103: 438-45 (2015)
Martin-Luther-Universit£t Halle-Wittenberg
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities fora4ß2 neuronal nicotinic acetylcholine receptors.
Eur J Med Chem 103: 429-37 (2015)
University of Sassari
Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis.
J Med Chem 58: 7888-94 (2015)
Merck Research Laboratories
1,4-Oxazineß-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads.
J Med Chem 58: 8216-35 (2015)
Janssen Pharmaceutica NV
Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors.
Bioorg Med Chem Lett 25: 4457-60 (2015)
University of Milan
Quaternary Indolizidine and Indolizidone Iminosugars as Potential Immunostimulating and Glycosidase Inhibitory Agents: Synthesis, Conformational Analysis, Biological Activity, and Molecular Docking Study.
J Med Chem 58: 7820-32 (2015)
Savitribai Phule Pune University (Formerly University of Pune)
Pentafluorosulfanyl-containing flufenamic acid analogs: Syntheses, properties and biological activities.
Bioorg Med Chem Lett 25: 4437-40 (2015)
RWTH Aachen University
Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.
Bioorg Med Chem Lett 25: 4447-52 (2015)
Alexandru Ioan Cuza University
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes.
Bioorg Med Chem Lett 25: 4428-33 (2015)
National Institute of Pharmaceutical Education and Research-Ahmedabad
Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
Bioorg Med Chem 23: 6659-65 (2015)
Chungnam National University
Reengineered tricyclic anti-cancer agents.
Bioorg Med Chem 23: 6528-34 (2015)
Icahn School of Medicine at Mt. Sinai
Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.
J Med Chem 59: 4210-20 (2016)
University of California Irvine
New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition.
J Med Chem 59: 1492-500 (2016)
University of Dundee
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
Eur J Med Chem 103: 370-3 (2015)
IQM-CSIC
Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.
J Med Chem 58: 7719-33 (2015)
Heidelberg University
Design, Virtual Screening, and Synthesis of Antagonists ofaIIbß3 as Antiplatelet Agents.
J Med Chem 58: 7681-94 (2015)
A.V. Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine
Chemical Synthesis and Biological Activities of 20S,24S/R-Dihydroxyvitamin D3 Epimers and Their 1a-Hydroxyl Derivatives.
J Med Chem 58: 7881-7 (2015)
Veterans Affairs Medical Center
Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitors.
Bioorg Med Chem 23: 6763-73 (2015)
Shenyang Pharmaceutical University
Progress in the development of fatty acid synthase inhibitors as anticancer targets.
Bioorg Med Chem Lett 25: 4363-9 (2015)
University of South Alabama
Structure and Inhibition of Microbiome ß-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.
Chem Biol 22: 1238-49 (2015)
University of North Carolina at Chapel Hill
Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.
Eur J Med Chem 103: 361-9 (2015)
Alzahra University
Discovery of WQ-3810: Design, synthesis, and evaluation of 7-(3-alkylaminoazetidin-1-yl)fluoro-quinolones as orally active antibacterial agents.
Eur J Med Chem 103: 354-60 (2015)
Wakunaga Pharmaceutical Co., Ltd.
Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors.
Eur J Med Chem 103: 343-53 (2015)
Shenyang Pharmaceutical University
3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Eur J Med Chem 103: 325-34 (2015)
NorthShore University HealthSystem
¿(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.
Eur J Med Chem 103: 312-24 (2015)
Universit£ degli Studi di Parma
New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Eur J Med Chem 103: 302-11 (2015)
1st Affiliated Hospital of Guangxi Medical University
Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.
Eur J Med Chem 103: 289-301 (2015)
Suven Life Sciences Ltd.
Discovery of highly potent renin inhibitors potentially interacting with the S3' subsite of renin.
Eur J Med Chem 103: 269-88 (2015)
China Pharmaceutical University
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.
Eur J Med Chem 103: 252-68 (2015)
University of Illinois at Chicago
Synthesis, In vitro and Docking Studies of New Flavone Ethers as a-Glucosidase Inhibitors.
Chem Biol Drug Des 87: 361-73 (2016)
Universiti Teknologi MARA
Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp(2)-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts.
Eur J Med Chem 121: 880-891 (2016)
University of Seville
(2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.
Eur J Med Chem 103: 238-51 (2015)
Jagiellonian University Medical College
Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target.
J Med Chem 58: 7707-18 (2015)
The University of Sydney
Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation.
Bioorg Med Chem 23: 6246-9 (2015)
Hokkaido University
Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores.
Bioorg Med Chem Lett 25: 4370-81 (2015)
Bayer HealthCare AG
Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.
Bioorg Med Chem Lett 25: 5419-23 (2015)
Daiichi Sankyo Co., Ltd
Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries.
J Med Chem 58: 7419-30 (2015)
University of Minnesota
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
J Med Chem 59: 788-809 (2016)
Georgia Institute of Technology
Discovery, Development, and SAR of Aminothiazoles as LIMK Inhibitors with Cellular Anti-Invasive Properties.
J Med Chem 58: 8309-13 (2015)
Cancer Research Technology
OpenGrowth: An Automated and Rational Algorithm for Finding New Protein Ligands.
J Med Chem 59: 4171-88 (2016)
Harvard University
Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K).
J Med Chem 58: 7431-48 (2015)
GlaxoSmithKline
Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
Eur J Med Chem 103: 210-22 (2015)
Korea University of Science and Technology (UST)
Structure-activity relationships for lipoprotein lipase agonists that lower plasma triglycerides in vivo.
Eur J Med Chem 103: 191-209 (2015)
Ume£ University
Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
Eur J Med Chem 103: 185-90 (2015)
Hefei University of Technology
Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists.
Eur J Med Chem 103: 175-84 (2015)
The University of Queensland
Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors.
Eur J Med Chem 103: 163-74 (2015)
University of Franche-Comt£
Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.
J Med Chem 58: 7833-49 (2015)
University of Kansas
Benzimidazole Derivatives as Potent JAK1-Selective Inhibitors.
J Med Chem 58: 7596-602 (2015)
Konkuk University
Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9.
Bioorg Med Chem 23: 6280-96 (2015)
The University of Melbourne
Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening.
J Med Chem 58: 7807-19 (2015)
National Health Research Institutes
Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction.
J Med Chem 58: 7186-94 (2015)
University College London
Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues.
J Med Chem 58: 7785-95 (2015)
University of Montpellier
Phosphate Chemical Probes Designed for Location Specific Inhibition of Intracellular Carbonic Anhydrases.
J Med Chem 58: 7580-90 (2015)
Griffith University
Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain.
Bioorg Med Chem 23: 6271-9 (2015)
University of Tsukuba
Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Bioorg Med Chem Lett 25: 4664-71 (2015)
Nanjing University
Ynamide Click chemistry in development of triazole VEGFR2 TK modulators.
Eur J Med Chem 103: 105-22 (2015)
University of Strasburg
Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 Inhibitors.
Bioorg Med Chem 23: 6335-45 (2015)
University of Eastern Finland
Synthesis and biological evaluation of novel 7-substituted 3-(4-phenoxyphenyl)thieno[3,2-c]pyridin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors.
Bioorg Med Chem 23: 6250-7 (2015)
Xi'an Jiaotong University
Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Bioorg Med Chem 23: 6467-76 (2015)
NorthShore University HealthSystem
Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors.
Bioorg Med Chem 23: 6497-509 (2015)
Universidade do Minho
New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibitinga-glucosidase and free radicals.
Bioorg Med Chem Lett 25: 4529-33 (2015)
Chulalongkorn University
Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.
Bioorg Med Chem Lett 25: 4481-6 (2015)
The Catholic University of Korea
Identification of novel PARP-1 inhibitors: Drug design, synthesis and biological evaluation.
Bioorg Med Chem Lett 25: 4557-61 (2015)
China Pharmaceutical University
Discovery of 6-phenylimidazo[2,1-b]thiazole derivatives as a new type of FLT3 inhibitors.
Bioorg Med Chem Lett 25: 4534-8 (2015)
Sichuan University
Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents.
Bioorg Med Chem 23: 6379-88 (2015)
Research Triangle Institute
Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Eur J Med Chem 103: 91-104 (2015)
Tianjin Medical University
Discovery of novel VEGFR-2 inhibitors. Part 5: Exploration of diverse hinge-binding fragments via core-refining approach.
Eur J Med Chem 103: 80-90 (2015)
The First Affiliated Hospital of Xi'an Jiaotong University
Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.
J Med Chem 59: 487-96 (2016)
National Cancer Institute-CRO
Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors.
Bioorg Med Chem Lett 25: 4728-32 (2015)
Genentech
Discovery and SAR study of 3-(tert-butyl)-4-hydroxyphenyl benzoate and benzamide derivatives as novel farnesoid X receptor (FXR) antagonists.
Bioorg Med Chem 23: 6427-36 (2015)
East China University of Science and Technology
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
Bioorg Med Chem 23: 6486-96 (2015)
Korea Institute of Science and Technology
Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.
Bioorg Med Chem 23: 6418-26 (2015)
Chonnam National University
Multifunctional novel Diallyl disulfide (DADS) derivatives withß-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Bioorg Med Chem 23: 6389-403 (2015)
University of Delhi
Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.
J Med Chem 58: 7485-500 (2015)
Vanderbilt University Medical Center
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
J Med Chem 58: 7512-25 (2015)
Universit£ degli Studi di Urbino"Carlo Bo"
Phenolic Compounds from the Leaves and Twigs of Osteomeles schwerinae That Inhibit Rat Lens Aldose Reductase and Vessel Dilation in Zebrafish Larvae.
J Nat Prod 78: 2249-54 (2015)
Institute of Oriental Medicine
Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.
J Med Chem 58: 7850-62 (2015)
University of Groningen
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importina-2 Expression, and Induce Antitumor Effects against Human Glioma.
J Med Chem 58: 7734-48 (2015)
University of Hawaii at Hilo
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.
J Med Chem 58: 7672-80 (2015)
Guangzhou Institute of Biomedicine and Health
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.
J Med Chem 58: 7763-74 (2015)
University of Alabama at Birmingham
Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective¿-opioid receptor agonists.
Bioorg Med Chem Lett 25: 4689-92 (2015)
Harvard Medical School
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.
Bioorg Med Chem Lett 25: 4683-8 (2015)
University of Arizona
Towards the evaluation in an animal disease model: Fluorinated 17ß-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme.
Eur J Med Chem 103: 56-68 (2015)
Saarland University
Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
J Med Chem 58: 7572-9 (2015)
University of Cape Town
Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity.
J Med Chem 58: 7938-48 (2015)
University of Dundee
Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro.
J Med Chem 58: 7328-40 (2015)
Kitasato University
Inhibition and Allosteric Regulation of Monomeric Phosphoenolpyruvate Carboxykinase by 3-Mercaptopicolinic Acid.
Biochemistry 54: 5878-87 (2015)
The University of Kansas Medical Center
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.
J Med Chem 58: 7400-8 (2015)
University of Toyama
Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as anticancer agents with low toxicity.
Bioorg Med Chem 23: 6477-85 (2015)
Xi'an Jiaotong University
Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists.
Bioorg Med Chem Lett 25: 4109-13 (2015)
Genentech
N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF.
Bioorg Med Chem Lett 25: 4104-8 (2015)
MRC Technology
Synthesis and Structure-Activity Relationships of Quaternary Coptisine Derivatives as Potential Anti-ulcerative Colitis Agents.
J Med Chem 58: 7557-71 (2015)
Chinese Academy of Medical Sciences and Peking Union Medical College
Orally bioavailable Syk inhibitors with activity in a rat PK/PD model.
Bioorg Med Chem Lett 25: 4642-7 (2015)
Novartis Institutes for BioMedical Research
Novel bivalent inhibitors with sub-nanomolar affinities towards human glyoxalase I.
Bioorg Med Chem Lett 25: 4724-7 (2015)
Chengdu University
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Bioorg Med Chem Lett 25: 4610-4 (2015)
South China Agricultural University
Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2).
Bioorg Med Chem Lett 25: 4265-9 (2015)
Bristol-Myers Squibb Pharmaceutical Research Institute
Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents.
Bioorg Med Chem 23: 6223-7 (2015)
Universit£ degli Studi di Firenze
Design and discovery of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4-phenyl)thiazole derivatives as cardiotonic agents via inhibition of PDE3.
Bioorg Med Chem 23: 6111-7 (2015)
DaQing Oil Field General Hospital
Development of a novel tricyclic class of potent and selective FIXa inhibitors.
Bioorg Med Chem Lett 25: 5437-43 (2015)
Merck Research Laboratories
Probing a 3,4'-bis-guanidinium diaryl derivative as an allosteric inhibitor of the Ras pathway.
Bioorg Med Chem Lett 25: 4287-92 (2015)
Trinity College
Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors.
Bioorg Med Chem Lett 25: 4085-91 (2015)
University of Technology Sydney
Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF.
Bioorg Med Chem Lett 25: 4097-103 (2015)
MRC Technology
Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
Eur J Med Chem 102: 600-10 (2015)
Hanyang University
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2.
Eur J Med Chem 103: 29-43 (2015)
Universit£ di Pisa
4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.
Eur J Med Chem 103: 1-16 (2015)
Birla Institute of Technology
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.
J Med Chem 59: 504-30 (2016)
Merck Research Laboratories
6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptora and the Proton-Coupled Folate Transporter in Human Tumors.
J Med Chem 58: 6938-59 (2015)
Duquesne University
Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
Bioorg Med Chem Lett 25: 4148-52 (2015)
University of Arizona
Dicarabrol, a new dimeric sesquiterpene from Carpesium abrotanoides L.
Bioorg Med Chem Lett 25: 4082-4 (2015)
Hunan University of Chinese Medicine
Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays.
Bioorg Med Chem Lett 25: 4069-73 (2015)
Dalian Medical University
Discovery, synthesis and biological evaluation of 2-(4-(N-phenethylsulfamoyl)phenoxy)acetamides (SAPAs) as novel sphingomyelin synthase 1 inhibitors.
Bioorg Med Chem 23: 6173-84 (2015)
Fudan University
Imidazopyridines as a source of biological activity and their pharmacological potentials-Infrared and Raman spectroscopic evidence of their content in pharmaceuticals and plant materials.
Bioorg Med Chem 23: 6087-99 (2015)
Wroclaw University of Economics
Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO).
J Med Chem 58: 7341-8 (2015)
Zhengzhou University
Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective
J Med Chem 58: 7526-48 (2015)
Eli Lilly and Company
Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
J Med Chem 58: 8200-15 (2015)
AstraZeneca
Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties.
Eur J Med Chem 102: 552-73 (2015)
Xinjiang Technical Institute of Physics and Chemistry
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
Eur J Med Chem 102: 540-51 (2015)
Shiv Nadar University
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.
Eur J Med Chem 102: 530-9 (2015)
University of Genoa
Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1.
Eur J Med Chem 102: 477-86 (2015)
Genomics Research Center
Discovery of indole-based tetraarylimidazoles as potent inhibitors of urease with low antilipoxygenase activity.
Eur J Med Chem 102: 464-70 (2015)
University of the Punjab
Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors.
Eur J Med Chem 102: 445-63 (2015)
Qilu Pharmaceutical Co., Ltd
6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.
J Med Chem 58: 7258-72 (2015)
Johns Hopkins University
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.
J Med Chem 58: 7370-80 (2015)
Novo Nordisk A/S
Novel 11ß-HSD1 inhibitors: C-1 versus C-2 substitution and effect of the introduction of an oxygen atom in the adamantane scaffold.
Bioorg Med Chem Lett 25: 4250-3 (2015)
Universitat de Barcelona
Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies.
J Med Chem 58: 6994-7006 (2015)
Purdue University
Discovery of Potent 17ß-Hydroxywithanolides for Castration-Resistant Prostate Cancer by High-Throughput Screening of a Natural Products Library for Androgen-Induced Gene Expression Inhibitors.
J Med Chem 58: 6984-93 (2015)
University of Arizona
A novel series of indazole-/indole-based glucagon receptor antagonists.
Bioorg Med Chem Lett 25: 4143-7 (2015)
Merck Research Laboratories
Exploration of the molecular architecture of the orthosteric binding site in thea4ß2 nicotinic acetylcholine receptor with analogs of 3-(dimethylamino)butyl dimethylcarbamate (DMABC) and 1-(pyridin-3-yl)-1,4-diazepane.
Eur J Med Chem 102: 425-44 (2015)
University of Copenhagen
Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Eur J Med Chem 102: 375-86 (2015)
American University of Ras Al Khaimah
Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.
Bioorg Med Chem 23: 6185-94 (2015)
University of Arizona
1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
Bioorg Med Chem 23: 6195-209 (2015)
Friedrich-Alexander University
Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors.
J Med Chem 58: 7349-69 (2015)
University of Minnesota
Discovery, synthesis and biochemical profiling of purine-2,6-dione derivatives as inhibitors of the human poly(A)-selective ribonuclease Caf1.
Bioorg Med Chem Lett 25: 4219-24 (2015)
University of Nottingham
Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.
Bioorg Med Chem Lett 25: 4158-63 (2015)
Eli Lilly and Company
Optimization of a small molecule probe that restores e-cadherin expression.
Bioorg Med Chem Lett 25: 4260-4 (2015)
Vanderbilt University Medical Center
The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors.
Bioorg Med Chem Lett 25: 4136-42 (2015)
Amgen Inc
Recent progress on MAP kinase pathway inhibitors.
Bioorg Med Chem Lett 25: 4047-56 (2015)
Ontario Institute for Cancer Research
Expanding the structural diversity of Bcr-Abl inhibitors: Hybrid molecules based on GNF-2 and Imatinib.
Bioorg Med Chem Lett 25: 4164-8 (2015)
Xi'an Jiaotong University
Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
Eur J Med Chem 102: 363-74 (2015)
China Pharmaceutical University
Conformationally restrained carbamoylcholine homologues. Synthesis, pharmacology at neuronal nicotinic acetylcholine receptors and biostructural considerations.
Eur J Med Chem 102: 352-62 (2015)
IQM-CSIC
Substrate-guided optimization of the syringolins yields potent proteasome inhibitors with activity against leukemia cell lines.
Bioorg Med Chem 23: 6218-22 (2015)
Brown University
3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.
Bioorg Med Chem 23: 6166-72 (2015)
Ewha Womans University
Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
Eur J Med Chem 102: 310-9 (2015)
Ochanomizu University
Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity.
J Med Chem 58: 7057-75 (2015)
AstraZeneca
Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution.
J Med Chem 59: 4202-9 (2016)
University of California San Diego
Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors.
ACS Med Chem Lett 6: 942-7 (2015)
Merck Research Laboratories
Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes.
ACS Med Chem Lett 6: 936-41 (2015)
Merck Research Laboratories
Discovery, SAR, and X-ray Binding Mode Study of BCATm Inhibitors from a Novel DNA-Encoded Library.
ACS Med Chem Lett 6: 919-24 (2015)
GlaxoSmithKline
Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis.
ACS Med Chem Lett 6: 913-8 (2015)
Genentech
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.
ACS Med Chem Lett 6: 908-12 (2015)
Bristol-Myers Squibb Research and Development
Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.
ACS Med Chem Lett 6: 902-7 (2015)
The University of Tokyo
Highly Efficient Synthesis of 1,3-Dihydroxy-2-carboxycarbazole and Its Neuroprotective Effects.
ACS Med Chem Lett 6: 894-7 (2015)
Virginia Commonwealth University
Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT).
ACS Med Chem Lett 6: 888-93 (2015)
GlaxoSmithKline
Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors.
ACS Med Chem Lett 6: 866-71 (2015)
Universit£ di Sassari
Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.
ACS Med Chem Lett 6: 861-5 (2015)
Merck Research Laboratories
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms.
ACS Med Chem Lett 6: 850-5 (2015)
Bristol-Myers Squibb R & D
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors.
ACS Med Chem Lett 6: 845-9 (2015)
Bristol-Myers Squibb Research & Development
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase.
ACS Med Chem Lett 6: 840-4 (2015)
Hebrew University-Hadassah Medical Center
Fatty Acid Synthase (FASN) Inhibitors as Potential Treatment for Cancer, Obesity, and Liver Related Disorders.
ACS Med Chem Lett 6: 838-9 (2015)
Therachem Research Medilab (India) Pvt. Ltd.
Fused Morphlinopyrimidines and Methods of Use Thereof.
ACS Med Chem Lett 6: 836-7 (2015)
Temple University School of Pharmacy
Inhibitors of the Renal Outer Medullary Potassium Channel.
ACS Med Chem Lett 6: 831-3 (2015)
Temple University School of Pharmacy
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
J Med Chem 58: 6747-52 (2015)
Novartis Institutes for BioMedical Research
Medicinal Chemistry Approaches to Heart Regeneration.
J Med Chem 58: 9451-79 (2015)
TU Dortmund University
Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library.
ACS Med Chem Lett 6: 882-7 (2015)
Universit degli Studi di Milano
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.
J Med Chem 58: 6784-802 (2015)
Amgen Inc
Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes.
J Med Chem 58: 7465-74 (2015)
University of Michigan
Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase anda-Glucosidase.
J Nat Prod 78: 1977-89 (2015)
Chinese Academy of Sciences
Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.
J Med Chem 58: 6803-18 (2015)
University College London
Prokineticin Receptor Modulators May Potentially Treat Psychiatric and Neurological Disorders.
ACS Med Chem Lett 6: 834-5 (2015)
Therachem Research Medilab (India) Pvt. Ltd.
Identification of inhibitors that target dual-specificity phosphatase 5 provide new insights into the binding requirements for the two phosphate pockets.
BMC Biochem 16: 19 (2015)
Texas Wesleyan University
Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration.
ACS Med Chem Lett 6: 898-901 (2015)
University of Michigan
Expanding the chemical space of human serine racemase inhibitors.
Bioorg Med Chem Lett 25: 4297-303 (2015)
University of Parma
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.
J Med Chem 58: 6928-37 (2015)
National Institute of Chemistry
Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds.
J Med Chem 58: 6899-908 (2015)
Baylor College of Medicine
Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders.
J Med Chem 58: 6710-5 (2015)
University of Jena
Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
Bioorg Med Chem 23: 5264-72 (2015)
Chonnam National University
Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17ß-hydroxysteroid dehydrogenase type 3.
Bioorg Med Chem 23: 5433-51 (2015)
CHU de Qu£bec-Research Center (CHUL)
Discovery of thieno[3,2-c]pyridin-4-amines as novel Bruton's tyrosine kinase (BTK) inhibitors.
Bioorg Med Chem 23: 6059-68 (2015)
China Pharmaceutical University
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent ROR¿t inverse agonists.
Bioorg Med Chem 23: 5293-302 (2015)
Fudan University
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
Eur J Med Chem 102: 223-32 (2015)
Universit£ degli Studi di Messina
Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residue.
Eur J Med Chem 102: 215-22 (2015)
Fudan University
Synthesis, biological evaluation, and docking studies of novel thiourea derivatives of bisindolylmethane as carbonic anhydrase II inhibitor.
Bioorg Chem 62: 83-93 (2015)
Universiti Teknologi MARA (UiTM)
Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1.
Bioorg Med Chem 23: 5483-8 (2015)
University of California
Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.
Bioorg Med Chem 23: 5390-401 (2015)
University of Tennessee Health Science Center
Antimalarial activity of prodrugs of N-branched acyclic nucleoside phosphonate inhibitors of 6-oxopurine phosphoribosyltransferases.
Bioorg Med Chem 23: 5502-10 (2015)
Academy of Sciences of the Czech Republic
Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
Bioorg Med Chem 23: 5489-95 (2015)
Stony Brook University
Total Synthesis of Hispidulin and the Structural Basis for Its Inhibition of Proto-oncogene Kinase Pim-1.
J Nat Prod 78: 1969-76 (2015)
Taiwan Academia Sinica
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach.
J Med Chem 58: 6844-63 (2015)
TU Dortmund University
Recent progress in the development of small-molecule glucagon receptor antagonists.
Bioorg Med Chem Lett 25: 4057-64 (2015)
Pfizer Inc
Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT1 F receptor agonists: Evolution from bicyclic to monocyclic cores.
Bioorg Med Chem Lett 25: 4337-41 (2015)
Eli Lilly and Company
Synthesis and Characterization of 5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC) and Its Analogues as Non-nitrogenous 5-HT2B Ligands.
J Nat Prod 78: 1859-67 (2015)
Virginia Commonwealth University
Fragment Binding Can Be Either More Enthalpy-Driven or Entropy-Driven: Crystal Structures and Residual Hydration Patterns Suggest Why.
J Med Chem 58: 6960-71 (2015)
Philipps University Marburg
Discovery of Potent and Selective RSK Inhibitors as Biological Probes.
J Med Chem 58: 6766-83 (2015)
Novartis Institutes for BioMedical Research
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38.
J Med Chem 58: 7021-56 (2015)
GlaxoSmithKline
Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists.
J Med Chem 58: 7931-7 (2015)
Kitasato University
Evaluation of transition-state mimics in a superior BACE1 cleavage sequence as peptide-mimetic BACE1 inhibitors.
Bioorg Med Chem 23: 5626-40 (2015)
Kyoto Pharmaceutical University
Phosphate-modified analogues of m(7)GTP and m(7)Gppppm(7)G-Synthesis and biochemical properties.
Bioorg Med Chem 23: 5369-81 (2015)
University of Warsaw
Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
Bioorg Med Chem 23: 5311-8 (2015)
University of Chieti-Pescara
Discovery of 1-hydroxypyridine-2-thiones as selective histone deacetylase inhibitors and their potential application for treating leukemia.
Bioorg Med Chem Lett 25: 4320-4 (2015)
University of Minnesota
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
J Nat Prod 78: 1937-41 (2015)
University of Shizuoka
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
J Med Chem 58: 7224-40 (2015)
Universit£ di Pisa
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
Proc Natl Acad Sci U S A 112: 10768-73 (2015)
University of Oxford
Tight binding enantiomers of pre-clinical drug candidates.
Bioorg Med Chem 23: 5326-33 (2015)
Victoria University of Wellington
Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.
Bioorg Med Chem 23: 5382-9 (2015)
Medical University of Sofia
Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors.
Bioorg Med Chem Lett 25: 3784-7 (2015)
Sejong University
Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase.
Bioorg Med Chem Lett 25: 3788-92 (2015)
Novartis Institutes for BioMedical Research
Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3.
J Med Chem 58: 7164-72 (2015)
Pfizer Inc
Development of Selective Covalent Janus Kinase 3 Inhibitors.
J Med Chem 58: 6589-606 (2015)
Harvard Medical School
Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor.
J Med Chem 58: 6410-21 (2015)
China Pharmaceutical University
The N-Terminal T-T Motif of a Third-Generation HIV-1 Fusion Inhibitor Is Not Required for Binding Affinity and Antiviral Activity.
J Med Chem 58: 6378-88 (2015)
Chinese Academy of Medical Sciences & Peking Union Medical College
Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity.
Eur J Med Chem 102: 115-31 (2015)
Jazan University
Strongylophorines, new protein tyrosine phosphatase 1B inhibitors, from the marine sponge Strongylophora strongilata collected at Iriomote Island.
Bioorg Med Chem Lett 25: 3900-2 (2015)
Tohoku Pharmaceutical University
Novel diazabicycloalkane delta opioid agonists.
Bioorg Med Chem 23: 5527-38 (2015)
Istituto di Farmacologia Traslazionale
Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase.
Bioorg Med Chem 23: 5466-75 (2015)
Chiba University
Synergistic activation of quorum sensing in Vibrio harveyi.
Bioorg Med Chem Lett 25: 3966-9 (2015)
National Institute for Biotechnology in the Negev
Boronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability.
Bioorg Med Chem Lett 25: 3793-7 (2015)
Syntrix Biosystems
Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors.
Bioorg Chem 62: 74-82 (2015)
Birla Institute of Technology
Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
Eur J Med Chem 102: 80-92 (2015)
Bezmialem Vakif University
Design, synthesis and RON receptor tyrosine kinase inhibitory activity of new head groups analogs of LCRF-0004.
Bioorg Med Chem Lett 25: 3810-5 (2015)
Laboratoires ChemRF Inc/ChemRF Laboratories Inc